Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
ALOXE3	"E-LOX, eLOX3"	ENSG00000179148	"Arachidonate lipoxygenase 3"	Q9BYJ1	17	8095900-8119047	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Isomerase, Lyase, Oxidoreductase"	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"skin 1: 30.2"	"Cell line enhanced"	"Detected in some"		"A-431: 6.5;HBEC3-KT: 10.6;hTCEpi: 7.8;hTERT-HME1: 14.8;T-47d: 4.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.9"	"Group enriched"	"Detected in many"	8	"basal ganglia: 1.1;cerebellum: 1.4;cerebral cortex: 2.3;pons and medulla: 1.1"	"Group enriched"	"Detected in some"	5	"gdT-cell: 1.0;naive CD4 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	28	"T-cells: 2.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA023120, HPA078597"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA023120: AB_10959300, HPA078597: "	"unprognostic (2.40e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.87e-3)"	"unprognostic (2.09e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.06e-2)"		"unprognostic (3.56e-4)"	"unprognostic (3.60e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.66e-5)"	"unprognostic (9.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.88e-2)"	0.1	0.0	0.1	0.1	1.1	0.0	1.6	1.4	2.3	1.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.0	0.1	0.1	0.1	0.1	30.2	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	1.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	2.7	0.2	6.5	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.1	0.4	0.1	0.5	0.2	0.2	0.1	0.4	0.9	10.6	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.8	0.1	14.8	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.7	0.0	4.7	0.0	0.1	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.1	1.4	2.3	0.1	0.1	0.1	0.1	1.1	0.1
AMACR	"P504S, RACE"	ENSG00000242110	"Alpha-methylacyl-CoA racemase"	Q9UHK6	5	33986178-34008108	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 68.0;liver: 63.6"	"Cell line enhanced"	"Detected in many"		"U-266/70: 58.5;U-266/84: 30.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 34.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001809, HPA019527, HPA020912"	Enhanced		Supported	"Vesicles,Plasma membrane"			65000	"Vesicles, Plasma membrane"		"CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034"	"unprognostic (8.96e-2)"	"unprognostic (5.20e-3)"	"prognostic favourable (7.11e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.59e-5)"	"unprognostic (1.95e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.32e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	2.8	8.3	5.2	2.7	8.2	0.9	2.8	4.7	7.8	4.4	14.1	4.3	6.5	6.2	4.0	3.6	8.2	2.3	11.0	3.5	4.5	6.8	68.0	63.6	3.3	2.0	4.5	4.5	2.9	5.1	5.4	4.3	3.2	7.0	13.9	15.5	5.5	25.4	5.4	6.0	2.6	7.4	3.7	3.8	2.9	15.9	2.1	2.1	3.8	3.3	3.4	3.3	5.7	4.5	7.8	10.2	11.2	14.2	9.9	10.0	6.8	4.0	6.5	3.7	4.7	2.6	4.0	6.3	5.4	4.0	2.5	1.9	21.1	4.9	1.3	2.9	7.6	1.9	0.9	3.9	2.6	4.0	3.4	3.1	4.7	6.1	1.8	1.9	1.0	6.1	1.9	3.2	1.2	2.8	1.1	4.8	7.3	2.9	1.5	2.4	3.3	10.6	1.9	6.1	2.0	11.1	20.3	2.0	2.8	8.9	6.4	5.4	4.9	1.9	5.0	8.3	1.8	2.0	4.3	58.5	30.5	2.3	2.3	3.9	6.1	0.3	7.1	10.2	10.0	8.8	8.4	7.8	8.7	7.8	10.2	7.0	8.1	6.1	11.2	9.9	14.2	5.3	8.9	6.8	5.2	8.2	4.7	7.8	4.5	6.8	4.5	4.5	7.0	2.1
BPGM		ENSG00000172331	"Bisphosphoglycerate mutase"	P07738	7	134646808-134679813	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Congenital erythrocytosis, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"placenta: 184.7"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 37.1;RT4: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016493, HPA028735"	Enhanced		Approved	Nucleoplasm,Nucleoli			69000000	Nucleoli	Nucleoplasm	"HPA016493: AB_1845414, HPA028735: AB_10600791"	"unprognostic (2.56e-1)"	"prognostic favourable (7.95e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.96e-1)"	"unprognostic (7.74e-2)"	"unprognostic (4.67e-3)"	"unprognostic (7.42e-2)"	"unprognostic (5.69e-2)"	"prognostic favourable (1.54e-8)"	"unprognostic (2.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.78e-2)"	6.1	7.3	13.6	4.5	11.1	37.7	6.9	11.7	11.6	7.1	6.9	9.1	6.1	4.3	5.4	10.2	14.6	4.7	6.9	7.3	12.5	14.2	19.1	8.1	8.0	5.2	13.9	7.8	5.7	5.4	16.5	14.4	184.7	12.4	7.5	5.4	6.7	10.6	10.3	17.7	5.5	6.0	6.6	15.9	8.6	6.8	7.4	8.8	8.5	7.5	22.2	13.3	24.9	9.5	11.6	10.2	28.2	12.8	9.8	14.5	12.8	4.4	5.4	7.2	9.7	8.3	4.9	7.2	13.4	16.2	5.2	7.8	2.1	6.0	5.4	4.0	7.5	3.6	7.6	7.4	9.2	37.1	6.7	3.1	5.0	2.5	5.7	5.9	4.1	4.8	6.7	9.8	5.3	18.9	9.0	6.8	12.3	2.1	9.6	8.2	7.4	5.2	7.3	5.1	3.9	11.8	59.6	6.2	10.4	6.2	7.5	6.7	4.9	3.8	14.3	8.3	2.0	11.1	10.8	11.3	12.9	6.8	14.4	5.7	14.2	28.2	9.8	27.6	14.5	12.8	10.4	11.6	9.5	12.7	10.2	10.5	13.2	13.4	18.0	9.8	12.5	6.7	12.0	12.8	13.6	11.1	11.7	11.6	12.5	14.2	13.9	7.8	12.4	8.8
CWC27	"NY-CO-10, SDCCAG-10, SDCCAG10"	ENSG00000153015	"CWC27 spliceosome associated protein homolog"	Q6UX04	5	64768930-65018763	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"			"Disease mutation, Dwarfism, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020344, HPA024149, HPA065809"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA020344: AB_1856644, HPA024149: AB_1856645, HPA065809: "	"unprognostic (1.71e-1)"	"unprognostic (6.47e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.91e-2)"	"unprognostic (4.00e-3)"	"prognostic unfavourable (5.27e-6)"	"unprognostic (1.58e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.45e-3)"	15.6	16.4	22.0	14.9	30.4	21.7	16.4	30.1	25.6	16.5	17.5	13.8	14.0	11.8	19.4	15.7	17.3	14.9	13.8	22.1	20.6	19.9	17.5	12.1	12.8	17.0	22.3	20.7	23.3	10.9	21.4	28.8	17.5	26.2	18.6	18.7	11.4	13.3	16.0	24.0	13.8	15.9	24.7	23.3	15.0	13.9	19.6	23.6	22.5	17.2	18.2	18.6	18.6	20.0	15.1	14.6	8.6	11.5	17.0	15.9	9.0	15.2	10.2	18.3	33.9	15.7	19.2	20.5	16.0	13.4	18.0	18.9	17.0	19.4	22.6	28.1	16.6	9.7	19.2	29.0	32.8	18.8	15.7	17.0	17.2	14.1	24.1	17.7	11.5	12.8	22.3	22.6	28.8	19.0	16.5	14.9	17.8	15.1	24.6	16.1	14.8	12.3	22.9	24.7	23.5	17.1	13.3	21.8	9.6	19.5	8.0	18.1	17.4	26.1	15.7	10.6	18.7	16.9	25.5	11.7	15.1	22.2	19.8	31.2	18.7	8.6	11.5	7.9	12.8	11.3	15.5	15.1	14.2	15.9	14.6	11.9	15.4	15.9	2.5	17.0	8.5	12.0	15.1	9.0	22.0	30.4	30.1	25.6	20.6	19.9	22.3	20.7	26.2	23.6
DCT	TYRP2	ENSG00000080166	"Dopachrome tautomerase"	P40126	13	94436808-94479682	"Enzymes, Predicted membrane proteins"	"Melanin biosynthesis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	58	"retina: 151.5;skin 1: 54.2"	"Cell line enriched"	"Detected in single"	259	"SK-MEL-30: 75.0"	"Cancer enriched"	"Detected in some"	215	"melanoma: 155.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010742, HPA010743, HPA010800, CAB017634"	Enhanced		Supported	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"CAB017634: AB_1130818, HPA010742: , HPA010743: AB_1847519, HPA010800: AB_1847520"	"unprognostic (5.99e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.06e-2)"	"unprognostic (6.18e-5)"	"unprognostic (6.97e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.42e-1)"	0.2	0.2	0.5	0.1	1.5	0.1	1.7	0.2	0.6	0.2	0.1	0.3	0.1	0.0	0.2	0.5	0.1	0.8	0.1	0.1	0.4	0.5	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.1	1.4	0.1	0.3	0.2	0.0	151.5	1.4	0.2	0.2	54.2	0.2	0.1	0.8	0.1	0.0	0.3	0.4	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.5	0.2	0.6	0.4	0.5	0.3	0.1	0.3	0.4
DSE	"DS-Epi1, DSEPI, SART2"	ENSG00000111817	"Dermatan sulfate epimerase"	Q9UL01	6	116254173-116444860	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 8.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA014764, HPA052151"	Uncertain		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Cytosol	"HPA014764: AB_1856587, HPA052151: "	"unprognostic (1.28e-1)"	"prognostic unfavourable (3.36e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavourable (6.34e-4)"	"unprognostic (5.11e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (6.19e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.10e-2)"	32.3	10.6	7.4	22.3	10.7	13.1	34.8	5.4	7.7	16.0	12.8	4.9	9.9	5.3	11.7	18.5	13.5	15.3	12.9	16.1	8.1	4.3	11.2	10.4	17.7	13.1	9.8	4.5	21.0	4.0	15.4	20.9	21.7	13.1	13.0	7.1	14.3	9.3	9.4	8.5	16.9	10.7	12.8	16.1	24.9	7.6	10.9	9.0	8.3	8.7	10.9	8.3	14.6	29.4	3.6	8.9	2.5	3.9	0.2	1.1	1.2	10.4	2.2	7.8	7.3	21.1	14.0	8.8	12.3	29.0	15.5	22.7	0.0	2.9	0.2	1.1	21.4	19.9	1.1	28.9	20.3	10.7	4.8	0.7	3.3	0.1	23.6	0.4	0.5	29.6	12.5	17.1	16.8	9.1	0.2	4.8	7.3	0.3	1.3	0.6	4.2	0.6	1.8	7.2	4.9	10.2	0.7	2.6	2.0	11.9	0.0	0.2	0.1	1.2	3.4	15.6	4.6	3.9	9.8	1.0	0.3	0.5	8.3	1.3	1.8	0.7	3.1	0.1	1.0	3.9	0.6	3.2	0.9	0.4	8.9	3.6	1.1	0.4	2.5	0.2	2.2	4.2	0.2	1.2	7.4	10.7	5.4	7.7	8.1	4.3	9.8	4.5	13.1	9.0
EBP	"CDPX2, CHO2, CPX, CPXD"	ENSG00000147155	"Emopamil binding protein (sterol isomerase)"	Q15125	X	48521158-48528716	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Isomerase	"Cataract, Disease mutation, Dwarfism, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003130	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA003130: AB_1078717"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.04e-2)"	"unprognostic (5.39e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.36e-1)"	3.7	33.2	5.3	4.3	5.7	10.5	10.5	10.1	6.3	8.6	19.6	2.8	3.4	17.2	4.0	3.7	20.6	3.9	4.5	21.7	4.7	4.3	12.8	74.1	14.9	13.0	3.5	8.0	4.8	11.7	6.0	3.7	4.2	8.8	8.6	15.7	5.2	8.7	4.8	3.5	9.1	30.0	5.6	7.0	7.9	8.1	5.4	2.8	9.0	4.6	9.8	10.4	5.0	10.0	17.1	22.9	21.5	12.6	13.3	29.9	18.1	33.0	7.0	18.6	11.1	10.4	7.7	6.0	8.5	7.1	11.3	16.3	13.9	55.3	17.9	6.0	5.9	37.3	31.1	45.9	8.6	13.7	15.5	9.0	9.4	11.9	7.6	33.2	22.4	7.5	16.7	15.1	11.2	7.5	11.5	17.0	9.2	14.5	18.4	20.4	18.6	23.0	12.8	1.8	50.7	27.6	5.9	15.8	8.0	31.3	16.1	4.4	17.7	7.9	7.8	5.8	9.8	22.4	9.2	7.3	11.4	18.1	13.5	33.5	5.5	17.4	8.9	21.5	29.9	11.7	25.1	17.1	22.2	27.5	12.3	12.6	20.1	25.5	1.8	13.3	12.6	22.9	22.4	18.1	5.3	5.7	10.1	6.3	4.7	4.3	3.5	8.0	8.8	2.8
ECI1	DCI	ENSG00000167969	"Enoyl-CoA delta isomerase 1"	P42126	16	2239395-2252300	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 90.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041746, HPA043227"	Enhanced		Enhanced	Mitochondria			11000000	Mitochondria		"HPA041746: AB_10960693, HPA043227: AB_10960273"	"unprognostic (4.99e-2)"	"prognostic favourable (3.04e-5)"	"unprognostic (3.75e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.85e-2)"	"prognostic favourable (1.07e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.66e-2)"	"prognostic favourable (8.99e-8)"	"unprognostic (2.61e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.08e-3)"	15.7	12.5	12.5	9.8	10.8	9.1	16.8	12.8	11.3	10.9	27.6	9.7	20.3	30.9	10.6	16.7	15.5	13.4	17.3	56.4	10.1	10.3	36.5	57.4	10.3	10.7	12.4	8.8	10.8	30.4	11.1	11.9	10.6	13.0	13.4	8.4	16.3	40.9	19.1	90.3	10.4	31.2	14.1	10.1	8.0	17.2	8.4	9.6	10.4	38.7	25.4	10.5	14.4	11.5	7.6	6.5	3.9	7.1	5.8	6.7	1.7	7.3	17.5	6.7	27.6	2.6	3.6	25.3	7.4	5.1	6.1	9.0	30.9	22.5	10.6	18.6	4.6	18.1	7.9	7.0	0.8	18.4	40.4	3.2	16.4	38.1	23.6	9.5	1.5	6.8	16.7	5.0	11.0	6.1	17.6	22.6	2.0	30.2	0.9	14.3	15.6	17.8	33.4	7.3	51.1	11.6	8.3	23.2	14.7	17.9	33.9	22.4	21.8	17.0	5.0	4.8	18.0	5.1	8.2	25.0	14.7	17.3	6.3	8.9	6.7	3.2	6.8	2.7	3.8	7.1	6.0	7.6	5.5	2.9	5.5	7.4	6.7	5.6	3.9	5.8	4.2	6.5	6.7	1.7	12.5	10.8	12.8	11.3	10.1	10.3	12.4	8.8	13.0	9.6
ECI2	"ACBD2, DRS1, HCA88, PECI"	ENSG00000198721	"Enoyl-CoA delta isomerase 2"	O75521	6	4115689-4135597	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 102.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA022130, HPA031626"	Enhanced		Enhanced	Peroxisomes,Mitochondria				"Peroxisomes, Mitochondria"		"HPA022130: AB_1855176, HPA031626: AB_2673965"	"unprognostic (2.36e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.00e-2)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (1.17e-3)"	"unprognostic (4.97e-2)"	"unprognostic (9.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.75e-2)"	"prognostic favourable (2.04e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.34e-1)"	17.9	29.2	13.2	7.3	17.4	4.5	17.0	8.9	9.5	15.7	18.0	10.7	14.9	16.2	15.2	26.2	10.6	12.7	12.4	32.1	10.3	11.1	56.8	102.3	7.4	8.9	13.3	7.2	19.0	59.2	8.9	17.2	11.1	10.3	14.6	14.0	13.3	9.0	10.5	45.7	5.6	22.7	10.3	11.9	10.1	23.2	11.9	9.3	13.3	17.7	26.6	7.5	12.6	8.9	20.6	25.1	7.0	16.2	25.5	27.7	16.7	17.8	9.7	16.3	35.4	20.5	30.5	2.0	25.3	26.0	27.7	24.8	7.3	2.7	0.7	31.9	27.5	9.4	18.5	14.7	40.3	6.7	21.2	9.4	13.8	39.3	11.9	8.5	4.7	21.0	9.1	23.5	13.2	57.6	30.8	6.9	26.2	7.1	24.0	21.2	11.0	34.9	23.3	20.2	0.3	14.9	3.6	0.3	7.6	1.5	10.6	22.4	24.5	4.0	58.1	20.9	11.5	18.4	15.0	10.6	18.8	1.8	10.7	7.5	16.1	6.9	15.5	7.0	18.9	11.5	25.9	19.9	22.3	26.4	25.1	20.6	27.7	27.1	0.4	25.5	16.2	19.2	23.6	16.7	13.2	17.4	8.9	9.5	10.3	11.1	13.3	7.2	10.3	9.3
EHHADH	ECHD	ENSG00000113790	"Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase"	Q08426	3	185190624-185281990	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 37.1;liver: 91.2"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in all"	7	"liver cancer: 42.2;renal cancer: 25.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036401, HPA042021"	Enhanced									"HPA036401: AB_10670165, HPA042021: "	"unprognostic (1.20e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.87e-1)"	"prognostic favourable (1.28e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.80e-1)"	4.1	1.2	1.2	1.7	1.4	0.1	1.5	0.5	1.2	1.7	6.4	0.8	0.4	5.2	1.0	2.0	2.9	0.8	3.0	3.2	1.2	0.9	37.1	91.2	1.9	1.0	1.7	0.7	0.8	2.5	2.7	0.9	1.3	2.1	1.7	2.6	8.3	2.7	0.4	0.7	1.1	9.9	1.0	1.4	1.7	2.4	0.9	0.9	1.4	2.1	1.7	1.2	1.8	1.0	1.5	6.0	0.2	2.2	2.7	2.7	1.1	8.2	3.5	1.0	0.0	5.2	4.5	1.1	4.0	1.2	2.6	2.9	15.1	5.2	0.0	15.7	3.9	4.0	0.0	3.3	5.5	11.0	3.7	5.8	0.9	15.2	3.4	0.7	0.1	6.3	4.3	2.6	2.4	3.8	3.8	4.3	5.0	4.3	0.1	3.4	2.1	4.4	0.0	7.0	0.3	10.8	4.7	3.1	4.5	7.8	4.5	7.2	16.6	6.8	1.8	1.7	2.6	1.3	0.3	1.2	3.7	0.3	0.5	2.6	2.8	0.2	2.2	0.0	1.6	2.1	1.0	1.5	1.1	2.4	6.0	0.2	1.6	2.7	0.1	2.7	2.0	2.4	1.4	1.1	1.2	1.4	0.5	1.2	1.2	0.9	1.7	0.7	2.1	0.9
FKBP10	"FKBP6, FLJ20683, FLJ22041, FLJ23833, hFKBP65"	ENSG00000141756	"FK506 binding protein 10"	Q96AY3	17	41812680-41823217	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Isomerase, Rotamase"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 72.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051171, HPA057021"	Enhanced		Approved	Vesicles	"Intracellular and membrane"		5500	Vesicles		"HPA051171: , HPA057021: "	"unprognostic (8.30e-2)"	"prognostic unfavourable (4.16e-4)"	"unprognostic (9.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.34e-2)"	"unprognostic (5.77e-2)"	"prognostic unfavourable (3.43e-5)"	"prognostic unfavourable (4.99e-4)"	16.9	16.5	6.6	13.2	7.2	0.2	14.9	3.4	8.4	43.0	11.5	6.0	15.8	3.8	42.7	39.0	14.0	21.4	28.6	19.2	5.6	3.6	10.3	3.2	16.2	17.1	5.3	6.7	35.5	13.5	24.7	22.7	33.8	5.2	21.3	5.7	17.1	6.5	17.0	9.6	8.8	7.6	27.9	5.5	7.9	8.5	15.1	5.7	1.2	16.9	9.5	8.1	24.4	19.2	0.3	0.0	0.0	0.0	2.0	0.9	0.1	0.0	16.1	14.9	48.7	52.4	61.2	13.1	66.3	66.4	25.0	21.6	8.3	0.6	0.0	0.9	72.0	0.1	8.9	17.7	10.6	4.4	13.3	6.4	18.1	23.8	57.2	0.0	0.0	65.7	0.0	20.5	15.7	21.2	0.2	2.3	20.8	20.9	0.0	0.0	11.6	5.4	1.3	17.5	2.1	4.3	0.0	3.7	13.0	0.1	47.7	22.2	7.5	0.4	24.0	30.2	15.7	20.0	10.1	0.1	0.0	0.0	41.3	0.0	28.7	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.9	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.1	6.6	7.2	3.4	5.8	5.6	3.6	5.3	6.7	5.2	5.7
FKBP11	FKBP19	ENSG00000134285	"FK506 binding protein 11"	Q9NYL4	12	48921518-48926474	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 175.6;salivary gland: 62.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 46.2;Karpas-707: 42.0;RPMI-8226: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 37.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041709	Enhanced		Approved	Centrosome				Centrosome		"HPA041709: AB_10794487"	"unprognostic (7.45e-3)"	"unprognostic (8.62e-2)"	"unprognostic (2.40e-1)"	"prognostic favourable (7.09e-4)"	"unprognostic (1.70e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.64e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.15e-1)"	"unprognostic (4.51e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.54e-1)"	5.6	4.6	1.1	8.2	1.4	3.7	3.7	0.9	2.2	7.5	6.9	0.9	21.6	9.2	4.4	12.9	4.4	4.8	8.1	3.4	1.3	2.4	4.8	38.4	5.8	16.6	1.0	1.3	3.7	175.6	0.2	12.3	3.3	1.6	4.8	6.3	1.9	62.0	20.9	1.4	1.7	7.6	2.9	1.0	18.7	10.0	1.9	0.9	2.2	4.7	4.9	14.5	8.2	4.3	11.1	8.3	1.1	0.3	5.1	37.6	7.3	2.1	2.8	0.5	0.7	12.6	19.1	1.0	16.6	23.9	18.4	21.8	10.7	12.0	32.4	0.5	27.2	8.9	5.8	7.3	9.6	6.8	1.2	1.2	3.0	0.1	46.2	0.6	0.9	21.3	14.2	14.1	26.3	10.4	0.4	42.0	6.7	6.0	4.8	1.1	1.4	5.3	13.3	0.8	42.0	2.3	0.4	6.9	2.0	5.5	8.3	3.7	0.5	1.0	8.3	3.6	0.7	0.3	0.3	24.6	20.3	16.4	2.2	0.7	5.9	0.9	0.2	0.6	22.5	0.3	37.6	11.1	15.6	17.7	0.3	4.8	9.4	14.4	1.1	5.1	0.1	8.3	6.4	7.3	1.1	1.4	0.9	2.2	1.3	2.4	1.0	1.3	1.6	0.9
FKBP14	"FKBP22, FLJ20731"	ENSG00000106080	"FK506 binding protein 14"	Q9NWM8	7	30010587-30026684	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Isomerase, Rotamase"	"Deafness, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013329, HPA026829"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"			Cytosol	"Nucleoplasm, Golgi apparatus"	"HPA013329: AB_1848613, HPA026829: AB_10601651"	"prognostic unfavourable (1.60e-4)"	"unprognostic (1.12e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.41e-3)"	"prognostic unfavourable (6.87e-4)"	"unprognostic (6.06e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.93e-3)"	"prognostic unfavourable (4.57e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-3)"	"prognostic unfavourable (4.25e-4)"	8.8	7.4	8.7	9.2	7.3	5.1	8.8	17.6	7.7	14.9	7.8	4.1	6.9	4.2	12.1	14.2	8.0	8.1	8.5	9.8	7.1	5.2	5.4	9.2	7.6	8.1	9.2	5.2	13.0	9.8	8.6	27.8	10.7	7.1	9.8	6.9	8.4	7.6	10.9	3.3	6.4	5.3	18.8	8.1	6.7	7.2	4.2	7.1	2.6	5.6	5.9	7.7	13.4	8.7	1.6	3.3	2.7	1.2	1.0	1.6	0.6	3.4	2.6	7.3	17.0	19.1	24.5	3.4	17.5	16.4	6.1	12.0	2.2	2.2	1.2	8.3	15.3	7.5	4.1	6.4	12.3	0.6	5.8	2.7	4.9	6.4	9.7	1.9	4.8	15.3	6.7	10.6	12.6	13.5	4.4	2.5	11.0	1.4	1.0	2.4	3.8	4.7	0.0	4.9	4.0	6.1	3.0	1.9	6.4	6.2	14.0	4.3	3.2	2.6	10.9	6.6	7.7	11.2	6.9	3.9	4.0	2.1	9.3	1.9	20.3	1.9	1.2	1.2	1.3	0.8	1.0	1.1	1.6	1.1	2.2	1.6	1.5	1.3	2.7	1.0	0.5	3.3	1.4	0.6	8.7	7.3	17.6	7.7	7.1	5.2	9.2	5.2	7.1	7.1
FKBP1A	"FKBP-12, FKBP1, FKBP12, FKBP12C, PKC12, PPIASE"	ENSG00000088832	"FK506 binding protein 1A"	P62942	20	1368978-1393172	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Isomerase, Rotamase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 149.0;TIME: 172.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 63.6;granulocytes: 88.4;monocytes: 94.3"									"CAB004639, HPA051798"	Uncertain						16000000			"CAB004639: AB_425434, HPA051798: "	"unprognostic (4.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.18e-3)"	"prognostic unfavourable (3.44e-7)"	"unprognostic (7.05e-3)"	"unprognostic (2.76e-1)"	"unprognostic (8.81e-2)"	"unprognostic (5.12e-3)"	"unprognostic (6.65e-2)"	"prognostic unfavourable (6.69e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	106.0	42.4	67.3	55.0	114.8	44.4	63.5	15.8	55.8	33.2	39.7	22.1	33.8	32.7	45.5	45.9	42.7	33.8	32.0	36.4	51.7	30.6	41.9	41.7	59.2	84.1	26.0	36.5	41.7	57.7	20.6	21.7	65.0	22.5	34.4	49.4	21.4	30.8	40.6	38.9	31.5	37.1	56.0	23.3	68.0	33.0	21.1	28.4	47.4	62.2	39.7	48.3	48.1	37.0	13.3	63.6	88.4	94.3	14.5	18.6	84.3	69.9	19.4	15.5	22.4	52.4	65.7	20.4	44.5	30.2	35.7	33.1	19.3	27.2	28.6	14.3	41.4	32.2	19.9	81.3	46.9	8.2	21.7	29.4	9.1	36.8	32.2	34.1	16.3	38.2	26.0	32.9	34.0	149.0	26.9	14.7	41.9	8.7	33.3	47.0	33.2	38.0	28.6	27.0	34.7	46.0	17.7	25.8	19.5	22.0	44.3	73.6	17.4	29.1	172.6	132.5	22.2	28.2	32.8	7.4	15.9	30.0	22.8	34.6	29.3	23.9	79.4	88.4	11.5	94.3	10.2	12.8	13.9	13.2	63.6	13.3	14.8	14.2	77.9	14.5	90.3	31.6	18.6	84.3	67.3	114.8	15.8	55.8	51.7	30.6	26.0	36.5	22.5	28.4
FKBP1B	"FKBP12.6, FKBP1L, FKBP9, OTK4, PPIase"	ENSG00000119782	"FK506 binding protein 1B"	P68106	2	24049701-24063681	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 31.1;intestine: 24.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 22.8;NTERA-2: 22.2;SH-SY5Y: 16.1;TIME: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 5.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA045572, HPA051798"	Uncertain		Approved	Vesicles				Vesicles		"HPA045572: , HPA051798: "	"unprognostic (3.01e-3)"	"unprognostic (3.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.45e-1)"	2.9	5.9	25.0	2.8	30.7	1.9	5.9	15.7	23.1	5.1	7.2	1.6	7.4	24.9	3.6	4.2	4.5	4.5	7.1	3.4	31.1	14.0	4.4	4.6	9.0	2.2	13.0	19.7	4.6	4.9	6.4	2.8	5.6	7.9	5.1	4.6	2.4	3.3	9.2	1.1	3.6	6.7	4.0	5.2	1.8	13.3	1.6	4.4	0.6	5.0	1.1	3.2	7.1	3.5	1.5	2.2	4.4	0.8	0.3	5.4	1.1	0.1	1.0	8.9	0.0	5.6	2.2	3.1	3.0	3.1	1.3	1.9	0.6	1.0	0.0	2.2	5.2	3.4	13.1	10.2	0.8	1.5	8.4	3.0	0.1	22.8	2.1	0.0	7.3	2.1	2.4	3.0	0.6	8.3	0.7	0.0	2.9	0.1	0.9	0.0	22.2	1.5	1.5	0.7	0.0	1.0	0.6	2.2	16.1	0.1	0.0	2.8	0.6	1.1	19.4	0.0	2.8	0.1	0.7	0.5	0.2	0.0	3.2	0.0	0.7	1.3	0.8	4.4	0.3	0.7	0.0	0.3	0.6	0.5	2.2	1.5	0.0	0.2	0.1	0.3	0.0	0.4	5.4	1.1	25.0	30.7	15.7	23.1	31.1	14.0	13.0	19.7	7.9	4.4
FKBP2	"FKBP-13, PPIase"	ENSG00000173486	"FK506 binding protein 2"	P26885	11	64241003-64244132	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 119.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025561, HPA049405"	Enhanced		Approved	"Plasma membrane"	"Intracellular and membrane"		400000	"Plasma membrane"		"CAB025561: , HPA049405: "	"unprognostic (4.94e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.66e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.23e-1)"	"unprognostic (5.91e-3)"	"unprognostic (5.86e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.23e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.57e-2)"	18.2	35.8	28.9	20.2	35.5	12.1	20.2	18.8	27.1	31.3	28.0	20.3	87.8	39.0	24.4	102.7	20.8	25.5	30.3	28.0	29.7	35.7	40.3	89.6	18.8	17.0	39.3	24.8	22.1	107.2	34.0	57.2	59.2	29.0	26.1	21.9	19.4	59.3	116.6	11.8	18.5	30.2	19.7	28.5	20.9	31.1	19.8	20.6	12.4	63.2	18.6	18.8	21.3	23.9	21.3	119.6	29.0	25.4	20.0	30.7	15.5	24.0	31.7	17.2	34.7	37.2	21.3	24.4	29.2	29.6	22.1	20.6	31.2	54.2	17.8	46.5	35.8	31.5	13.6	24.2	10.5	22.1	11.8	19.8	42.2	31.9	48.9	16.4	27.8	24.7	36.1	29.2	32.4	17.5	14.8	53.4	26.2	39.8	17.9	25.9	20.0	28.6	16.0	17.0	64.9	39.9	24.1	24.0	20.9	20.0	56.7	32.1	21.8	14.2	16.6	26.6	23.7	42.2	15.6	32.5	10.1	14.5	35.6	17.3	30.0	29.0	24.5	3.4	24.1	25.4	30.7	21.3	19.2	23.3	23.2	20.5	13.0	18.1	9.1	20.0	20.8	119.6	7.1	15.5	28.9	35.5	18.8	27.1	29.7	35.7	39.3	24.8	29.0	20.6
FKBP3	"FKBP-25, PPIase"	ENSG00000100442	"FK506 binding protein 3"	Q00688	14	45115600-45135319	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 113.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000864, CAB012232, CAB012520"	Supported		Supported	Cytosol			980000	Cytosol		"CAB012232: , CAB012520: AB_873554, HPA000864: AB_1078873"	"unprognostic (7.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.82e-3)"	"unprognostic (3.58e-3)"	"unprognostic (2.28e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.22e-3)"	"unprognostic (7.47e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.47e-1)"	11.7	13.2	28.1	10.2	40.7	9.8	15.5	25.1	32.1	12.0	14.6	11.4	8.3	13.2	9.9	20.4	14.6	8.8	9.1	31.3	26.0	24.4	16.5	20.5	8.0	14.6	23.2	23.8	9.9	10.9	15.0	17.1	14.0	22.9	17.9	15.2	6.6	10.7	12.2	113.3	11.3	13.9	12.8	19.6	9.9	10.6	13.5	22.4	12.7	12.4	24.2	16.5	12.7	9.3	19.5	27.5	13.5	17.4	15.4	19.4	13.0	36.9	41.2	60.0	31.5	26.7	29.2	23.7	22.7	26.1	36.0	39.7	36.0	31.8	19.7	24.0	25.6	30.8	44.5	29.3	51.3	28.5	26.6	16.2	32.0	46.5	26.4	28.0	17.6	27.5	30.6	20.9	19.5	46.8	23.4	14.9	42.6	45.2	44.8	37.5	30.4	39.1	43.2	44.2	23.9	57.5	42.8	36.6	14.3	36.4	22.7	34.8	53.1	21.0	30.1	27.5	47.6	14.4	17.4	25.1	44.6	30.7	16.6	19.3	25.6	11.6	14.6	13.5	13.0	17.2	15.7	19.5	17.5	17.6	21.8	13.6	16.8	18.8	2.3	15.4	17.4	27.5	19.4	13.0	28.1	40.7	25.1	32.1	26.0	24.4	23.2	23.8	22.9	22.4
FKBP4	"FKBP52, FKBP59"	ENSG00000004478	"FK506 binding protein 4"	Q02790	12	2794953-2805423	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"vagina: 209.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006148, CAB017441, HPA062857"	Approved		Enhanced	Nucleoplasm,Cytosol			110000	Cytosol	Nucleoplasm	"CAB017441: AB_10618759, HPA006148: AB_1078875, HPA062857: "	"unprognostic (1.46e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (7.65e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (6.12e-5)"	"prognostic unfavourable (1.44e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.22e-1)"	16.2	21.6	26.0	13.7	30.7	13.3	40.7	50.4	31.9	19.9	22.6	22.8	36.2	13.1	20.1	30.7	34.2	25.7	16.4	20.4	25.0	32.5	31.6	31.3	15.8	11.7	44.7	23.4	23.9	30.3	30.1	19.5	32.0	39.4	30.2	25.3	11.5	30.1	31.6	33.5	25.3	16.1	26.4	25.2	11.5	25.3	36.0	42.1	15.6	47.1	16.5	18.5	17.4	209.6	13.8	6.0	10.9	13.7	8.4	14.0	9.9	15.5	34.6	10.0	16.8	12.5	7.4	48.1	15.3	5.5	25.3	17.2	34.4	19.0	20.8	4.4	9.8	21.3	62.3	20.7	30.5	38.0	39.9	22.9	25.5	12.2	9.6	17.9	6.2	6.7	19.0	29.9	30.0	14.7	21.0	29.7	10.1	44.7	31.3	16.2	85.5	25.0	18.8	17.6	12.4	21.3	19.9	14.5	20.8	17.7	48.4	7.7	65.3	12.1	7.8	12.5	39.3	14.0	38.5	7.4	11.3	30.7	11.1	26.7	12.7	10.9	10.8	5.9	12.5	9.8	14.0	13.3	11.1	11.8	6.0	13.8	11.8	13.7	1.5	8.4	13.7	5.3	10.1	9.9	26.0	30.7	50.4	31.9	25.0	32.5	44.7	23.4	39.4	42.1
FKBP5	"FKBP51, FKBP54, P54, PPIase, Ptg-10"	ENSG00000096060	"FK506 binding protein 5"	Q13451	6	35573585-35728583	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 277.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 101.4;ASC TERT1: 63.1;HHSteC: 79.4;HSkMC: 95.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009315, HPA031092, HPA031093, HPA031095"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB009315: AB_2278350, HPA031092: AB_10600195, HPA031093: AB_10601748, HPA031095: "	"unprognostic (2.09e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.72e-1)"	"unprognostic (6.30e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.18e-3)"	"unprognostic (8.31e-2)"	"unprognostic (4.22e-2)"	"unprognostic (6.90e-3)"	78.8	20.7	9.5	14.2	15.6	4.9	36.7	2.4	10.9	16.5	29.0	5.1	29.8	2.2	18.6	16.9	29.2	19.4	17.9	26.3	10.6	4.2	44.9	30.7	19.7	55.9	15.7	3.6	27.2	43.7	8.6	33.8	6.0	13.1	18.3	8.2	11.8	30.4	25.1	277.2	20.2	36.7	18.6	18.2	32.3	25.0	14.3	12.4	20.1	24.2	9.8	16.8	22.5	18.4	4.0	30.6	24.9	31.2	11.8	42.3	39.9	4.9	2.1	9.5	14.2	101.4	63.1	0.1	2.7	0.1	1.7	4.1	3.7	0.8	24.5	2.5	0.5	0.0	5.6	11.9	4.2	9.6	5.3	10.5	1.8	5.2	79.4	6.6	1.0	95.9	48.2	3.1	29.1	10.3	11.2	10.0	18.6	3.1	27.3	12.4	2.4	1.6	12.2	2.4	11.9	7.9	3.0	3.6	2.2	2.2	2.5	0.5	14.0	7.8	22.7	2.5	2.2	0.3	3.7	4.5	5.2	31.1	0.8	12.9	0.9	13.7	31.2	19.4	20.0	27.0	23.8	3.0	28.2	20.8	30.6	4.0	42.3	30.2	24.9	11.8	12.0	9.2	10.3	39.9	9.5	15.6	2.4	10.9	10.6	4.2	15.7	3.6	13.1	12.4
FKBP7	FKBP23	ENSG00000079150	"FK506 binding protein 7"	Q9Y680	2	178463664-178478600	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 51.9;ASC TERT1: 32.2;HSkMC: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008707	Approved	Supported	Supported	"Endoplasmic reticulum"	"Intracellular and membrane"			"Endoplasmic reticulum"		"HPA008707: AB_1848624"	"unprognostic (1.33e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.96e-3)"	"prognostic unfavourable (4.61e-6)"	"unprognostic (3.50e-3)"	"unprognostic (1.34e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.10e-1)"	9.6	4.6	1.5	4.3	4.1	0.7	11.1	3.5	2.3	20.5	6.9	1.0	10.0	1.8	21.4	21.9	8.4	12.4	12.8	12.1	1.5	1.5	5.5	7.4	6.8	5.2	4.0	1.8	34.6	4.3	1.5	11.1	8.2	2.9	19.5	4.2	7.1	4.9	9.7	4.4	4.0	3.9	19.9	3.9	3.0	5.3	8.3	2.2	2.2	8.7	8.0	2.3	15.5	9.9	2.8	5.8	0.2	1.6	1.2	2.8	0.8	0.0	0.6	6.0	8.9	51.9	32.2	0.5	10.7	17.8	1.9	6.3	0.1	0.6	1.7	2.4	19.5	0.1	2.2	0.9	3.4	1.3	1.2	1.7	2.4	1.7	8.0	1.0	1.2	21.6	0.4	7.9	1.1	6.3	0.7	1.1	8.2	0.1	1.9	1.9	1.2	0.9	2.5	10.5	2.3	2.7	0.2	3.2	10.4	2.3	0.0	1.8	0.1	2.0	5.9	3.7	2.2	4.2	1.0	2.1	2.1	0.8	6.6	2.7	7.9	0.0	1.1	0.1	2.3	1.6	2.8	2.8	2.0	1.6	5.8	1.7	2.2	2.4	0.2	1.2	0.0	4.5	2.2	0.8	1.5	4.1	3.5	2.3	1.5	1.5	4.0	1.8	2.9	2.2
FKBP8	"FKBP38, FKBPr38"	ENSG00000105701	"FK506 binding protein 8"	Q14318	19	18531751-18544077	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Host-virus interaction"	"Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 32.5;neutrophil: 31.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025346, HPA045177"	Supported		Supported	"Endoplasmic reticulum,Mitochondria,Cytosol"				Mitochondria	"Endoplasmic reticulum, Cytosol"	"CAB025346: , HPA045177: "	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (8.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.22e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.49e-1)"	"prognostic favourable (7.76e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.32e-1)"	44.3	38.1	75.9	27.5	82.1	82.5	26.5	43.4	113.7	35.2	31.9	41.2	34.6	31.1	31.4	27.2	48.7	39.3	34.5	43.4	69.6	62.1	28.9	42.7	34.3	31.1	55.3	54.3	56.1	60.4	28.8	42.2	36.6	51.2	36.5	12.9	31.9	73.1	46.1	56.7	35.1	31.6	34.6	46.3	36.7	31.9	49.5	26.9	32.1	38.8	24.2	30.7	36.3	45.8	4.3	4.3	32.5	6.9	3.1	6.6	9.1	36.6	26.3	20.6	39.1	21.3	33.5	51.7	29.7	31.6	22.7	31.5	24.9	50.0	21.0	48.3	36.4	19.9	12.7	41.3	6.4	25.6	60.3	19.6	34.3	29.9	36.7	19.4	43.2	43.7	39.9	20.4	13.0	23.3	41.1	50.0	19.7	61.0	35.2	58.1	42.1	38.2	37.0	17.1	71.8	30.5	24.0	22.9	41.7	20.8	17.2	37.0	20.2	56.7	27.1	28.4	26.0	55.4	22.5	38.3	21.9	24.4	64.3	31.2	25.2	6.3	5.6	32.5	6.0	5.8	5.5	4.1	6.1	6.6	4.3	4.3	4.7	5.3	31.0	3.1	6.9	4.3	6.0	9.1	75.9	82.1	43.4	113.7	69.6	62.1	55.3	54.3	51.2	26.9
FKBP9	"FKBP60, FKBP63"	ENSG00000122642	"FK506 binding protein 9"	O95302	7	32957404-33006931	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 57.5;fHDF/TERT166: 70.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 7.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012595, HPA055256"	Approved		Approved	"Golgi apparatus,Vesicles,Mitochondria"	"Intracellular and membrane"			"Golgi apparatus, Mitochondria"	Vesicles	"HPA012595: AB_1848629, HPA055256: "	"unprognostic (1.23e-2)"	"prognostic unfavourable (4.22e-4)"	"unprognostic (6.94e-2)"	"unprognostic (6.25e-3)"	"prognostic unfavourable (5.80e-4)"	"prognostic unfavourable (2.02e-4)"	"prognostic unfavourable (8.69e-4)"	"unprognostic (3.40e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.90e-3)"	"prognostic unfavourable (7.02e-6)"	35.4	21.1	9.7	12.5	13.6	0.9	43.7	4.5	16.3	33.6	18.3	9.3	16.8	8.8	31.3	30.9	23.7	24.1	28.8	44.4	9.7	11.9	18.2	10.1	30.6	17.5	10.8	9.7	25.9	26.0	12.9	16.0	35.2	13.2	23.7	21.2	30.4	16.0	25.6	17.1	28.0	13.4	37.0	12.8	10.7	17.4	16.3	6.4	2.9	18.9	19.4	11.1	23.7	23.6	0.4	1.4	7.4	4.1	0.3	0.1	0.9	7.0	13.4	5.2	21.6	49.7	57.5	7.0	38.1	39.7	12.6	20.1	5.8	16.8	0.0	15.6	70.8	13.8	7.7	18.6	14.5	0.0	2.3	1.2	14.4	5.8	20.7	0.0	2.0	37.3	11.3	11.2	10.9	15.8	2.7	1.4	25.6	6.8	0.0	3.5	1.1	7.1	0.0	14.1	0.0	14.1	2.4	4.9	12.0	21.7	11.1	13.5	7.8	3.4	21.2	20.7	19.9	12.8	8.7	4.6	8.8	0.0	20.2	0.0	41.1	1.5	4.1	0.9	0.1	2.6	0.1	0.4	0.1	0.0	1.4	0.3	0.1	0.1	7.4	0.3	0.7	0.3	0.0	0.9	9.7	13.6	4.5	16.3	9.7	11.9	10.8	9.7	13.2	6.4
FUOM	"C10orf125, FLJ26016, FucM, FucU"	ENSG00000148803	"Fucose mutarotase"	A2VDF0	10	133355154-133358035	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 68.3"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"liver cancer: 61.0"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039207	Uncertain						2500000			"HPA039207: AB_10795033"	"unprognostic (1.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.48e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.82e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.25e-2)"	"unprognostic (7.56e-2)"	"unprognostic (4.50e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.65e-1)"	4.9	3.3	1.9	7.1	2.1	2.2	4.5	1.1	2.4	2.2	15.2	2.6	4.9	20.5	2.1	6.3	3.6	2.8	5.8	6.8	1.6	1.3	14.2	68.3	7.5	6.7	2.1	0.9	3.7	6.9	0.8	2.3	2.0	3.0	2.4	2.2	6.7	18.8	3.0	1.9	2.6	28.3	2.4	1.7	9.7	3.0	2.4	1.2	2.8	2.4	3.3	6.1	2.9	2.6	13.0	28.7	2.1	25.6	5.7	6.0	10.1	10.9	3.5	6.8	13.9	1.9	4.9	12.4	8.8	10.3	3.3	4.1	22.1	6.1	0.0	10.3	6.7	0.6	2.4	3.0	0.3	3.9	2.4	10.7	5.3	23.8	10.2	11.8	7.3	4.9	0.1	1.3	0.7	4.5	10.3	14.7	6.8	10.9	1.8	15.8	4.7	1.6	10.3	0.2	6.4	3.7	0.0	0.7	5.4	3.3	10.1	12.1	0.1	18.2	9.0	0.0	9.3	0.0	0.0	7.7	1.2	7.6	2.7	4.9	3.4	0.0	25.6	2.1	6.0	25.6	5.6	12.6	5.4	5.0	20.7	13.0	5.8	5.0	1.2	5.7	5.4	28.7	3.5	10.1	1.9	2.1	1.1	2.4	1.6	1.3	2.1	0.9	3.0	1.2
GALE	SDR1E1	ENSG00000117308	UDP-galactose-4-epimerase	Q14376	1	23795599-23800804	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007340			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA007340: AB_1078934"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.12e-1)"	"prognostic favourable (2.68e-4)"	"unprognostic (1.41e-2)"	4.4	5.5	4.8	5.6	6.1	1.8	5.0	4.3	8.7	9.1	22.3	3.2	12.4	20.0	3.0	6.0	26.2	6.4	34.7	3.7	4.0	4.1	18.2	26.1	7.7	3.9	3.7	5.2	2.4	15.9	7.7	3.5	29.4	3.5	4.8	23.8	5.5	32.1	6.9	1.7	3.9	30.4	4.1	3.6	8.6	46.7	3.4	2.6	3.7	2.3	9.8	19.6	8.1	8.4	3.1	10.6	2.0	18.6	19.4	5.2	4.7	16.2	19.5	7.8	12.4	2.9	4.1	7.6	11.1	15.0	19.7	14.7	17.8	54.5	3.8	15.6	6.5	18.0	6.9	28.4	15.0	8.2	4.5	10.9	9.9	19.3	29.8	4.7	3.2	8.8	15.0	18.1	45.5	16.9	12.1	1.0	14.0	17.3	7.7	5.0	2.2	19.0	9.2	7.6	4.9	31.9	10.9	3.0	6.9	20.1	18.3	19.7	13.4	3.9	9.2	14.4	21.4	14.8	13.6	5.0	12.1	5.0	15.2	20.0	7.7	1.1	7.7	1.7	5.1	15.5	5.2	3.1	3.1	4.1	10.6	1.0	3.6	2.5	2.0	19.4	18.6	3.0	5.1	4.7	4.8	6.1	4.3	8.7	4.0	4.1	3.7	5.2	3.5	2.6
GALM		ENSG00000143891	"Galactose mutarotase"	Q96C23	2	38665910-38741237	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 54.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 27.9;U-266/70: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 29.7"	"Group enriched"	"Detected in all"	5	"granulocytes: 13.2;T-cells: 29.7"	"Low region specificity"	"Detected in all"							"HPA035472, HPA035473, HPA064835"	Enhanced		Approved	Nucleoplasm			570000	Nucleoplasm		"HPA035472: AB_10669906, HPA035473: AB_2674642, HPA064835: AB_2732723"	"unprognostic (5.02e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.99e-3)"	"unprognostic (1.63e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.45e-2)"	"prognostic favourable (9.06e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.34e-1)"	"prognostic favourable (1.32e-4)"	11.2	54.2	3.1	10.4	2.5	0.7	4.6	1.9	2.7	5.9	28.4	2.5	44.3	22.7	6.8	11.8	3.4	11.6	13.3	7.7	2.5	1.8	39.1	28.8	5.8	6.4	2.4	1.9	6.4	7.9	10.4	2.4	3.1	2.9	8.1	10.7	15.3	7.9	29.1	4.6	2.2	39.8	5.4	3.3	4.1	5.0	4.7	2.1	6.4	7.4	3.3	9.3	6.5	5.2	2.8	4.5	13.2	2.1	2.3	29.7	5.3	0.0	10.7	3.3	0.0	11.1	6.5	5.9	1.3	4.0	3.0	4.9	11.9	5.6	4.1	7.9	5.9	1.7	4.6	0.3	6.0	18.8	7.8	2.2	2.9	23.8	4.0	0.9	0.1	4.5	0.1	6.8	0.0	3.4	6.3	27.9	5.5	0.3	9.1	14.8	5.0	3.5	5.7	0.2	8.1	3.9	18.4	0.6	4.7	0.0	7.6	5.4	3.7	2.1	1.3	1.0	0.2	7.4	0.4	31.3	21.2	0.1	6.9	2.6	0.1	13.2	2.1	1.8	10.2	1.5	15.0	2.8	16.0	14.8	4.5	2.5	5.8	5.0	5.1	2.3	0.2	0.4	29.7	5.3	3.1	2.5	1.9	2.7	2.5	1.8	2.4	1.9	2.9	2.1
GLCE	"HSEPI, KIAA0836"	ENSG00000138604	"Glucuronic acid epimerase"	O94923	15	69160584-69272217	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 49.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 58.4"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 4.0;monocytes: 4.4;T-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040481, HPA048216"	Uncertain		Approved	Mitochondria	"Intracellular and membrane"		78000	Mitochondria		"HPA040481: , HPA048216: "	"unprognostic (1.30e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.00e-2)"	"unprognostic (5.23e-1)"	"unprognostic (4.07e-2)"	8.3	12.2	6.5	4.9	14.2	0.6	8.8	58.4	12.1	8.4	12.1	12.4	7.8	13.5	6.3	6.9	10.2	5.9	7.2	5.5	5.8	8.5	13.3	16.0	8.4	5.3	9.4	8.1	12.9	5.9	9.0	12.0	12.6	14.4	5.7	14.0	10.8	11.7	8.9	4.1	9.8	11.2	6.8	10.2	4.0	8.8	6.1	7.6	5.4	4.1	8.4	5.8	6.3	5.6	0.6	4.0	0.1	4.4	0.5	4.0	1.9	3.9	3.5	2.3	4.1	8.0	7.7	0.8	7.3	9.7	5.6	10.8	2.9	9.8	2.3	3.6	5.9	5.8	5.0	4.7	11.6	0.9	5.6	3.9	6.6	2.9	7.8	1.7	8.1	5.2	3.3	7.0	8.0	49.9	1.5	2.5	10.6	2.3	1.0	2.9	1.1	2.4	2.3	9.6	2.9	5.2	4.1	7.6	1.6	7.4	4.6	15.4	3.3	2.4	17.3	5.5	6.8	6.0	6.4	1.0	1.5	0.5	5.5	2.8	7.9	0.0	4.4	0.1	0.7	3.4	1.2	0.6	1.8	0.8	3.6	0.5	1.2	1.5	0.1	0.5	4.4	4.0	4.0	1.9	6.5	14.2	58.4	12.1	5.8	8.5	9.4	8.1	14.4	7.6
GPI	"AMF, NLK"	ENSG00000105220	"Glucose-6-phosphate isomerase"	P06744	19	34359480-34402413	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Gluconeogenesis, Glycolysis"	"Cytokine, Growth factor, Isomerase"	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB018655, HPA024305, CAB040563, HPA052171"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"		140000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748"	"unprognostic (1.03e-1)"	"unprognostic (8.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.52e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.88e-2)"	62.1	66.6	43.4	27.6	58.2	83.3	34.8	62.6	88.7	20.6	36.6	20.8	23.7	48.2	21.1	20.6	45.3	24.2	33.5	107.2	42.0	45.6	51.3	77.9	19.6	29.6	39.3	64.3	22.5	21.4	66.9	33.7	20.4	50.2	23.7	37.2	36.2	34.6	33.9	144.7	29.4	44.3	34.2	22.8	23.1	26.7	19.7	19.0	23.8	26.1	68.5	32.6	32.5	25.2	16.2	26.3	74.8	40.9	14.5	27.5	24.6	76.1	107.4	9.4	73.5	30.9	23.0	22.5	29.4	23.2	37.1	44.8	60.5	27.0	50.2	43.7	28.8	53.1	56.8	63.9	42.2	55.8	22.9	64.5	51.8	63.6	20.0	83.5	42.0	31.5	26.4	43.9	22.8	34.6	32.8	39.8	26.1	64.6	36.3	29.2	25.4	38.0	34.0	24.9	94.8	46.5	51.3	51.4	29.9	59.3	104.6	21.4	23.7	26.6	29.8	14.0	30.9	39.8	45.3	73.5	41.7	45.5	46.8	63.5	28.4	38.5	22.9	74.8	22.5	35.2	27.5	16.2	20.7	25.5	26.3	13.3	17.5	20.7	1.6	14.5	40.9	8.7	21.6	24.6	43.4	58.2	62.6	88.7	42.0	45.6	39.3	64.3	50.2	19.0
GSTZ1	"GSTZ1-1, MAAI, MAI"	ENSG00000100577	"Glutathione S-transferase zeta 1"	O43708	14	77320884-77331597	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Isomerase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 90.4"	"Cell line enhanced"	"Detected in all"		"MCF7: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004701	Approved		Approved	Nucleoplasm,Cytosol			62000	Cytosol	Nucleoplasm	"HPA004701: AB_1078990"	"prognostic favourable (4.93e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-1)"	"prognostic favourable (3.73e-4)"	"unprognostic (7.90e-2)"	"unprognostic (1.73e-1)"	"prognostic favourable (1.12e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.92e-2)"	4.6	12.9	5.6	5.9	6.8	2.8	8.5	2.1	9.0	5.0	8.1	10.8	7.5	8.1	4.1	9.5	9.0	5.5	8.0	5.5	5.4	5.0	8.9	90.4	4.4	10.7	6.9	6.9	2.8	7.1	9.3	5.1	11.0	5.8	8.0	8.0	9.5	22.5	4.7	14.8	7.4	7.2	3.8	7.9	5.0	5.9	18.2	5.2	8.6	8.3	14.3	8.9	4.9	4.5	8.2	15.3	7.2	16.0	3.4	5.6	5.0	6.4	12.4	9.8	6.9	6.2	8.6	16.6	4.1	4.1	7.6	10.8	4.2	16.4	14.4	5.8	4.8	8.3	6.7	7.8	7.3	7.6	6.6	7.0	4.7	8.8	9.8	2.6	5.8	8.1	8.5	4.4	7.5	6.5	5.8	13.3	5.1	60.2	4.0	5.5	2.9	9.9	6.9	10.3	11.2	11.6	8.0	10.8	9.8	9.0	18.0	12.7	29.4	3.8	4.4	5.9	20.2	6.7	3.0	10.0	10.7	12.7	15.5	3.9	7.5	6.6	11.1	7.2	1.9	16.0	1.9	6.4	3.4	2.8	15.3	8.2	2.9	2.4	1.1	3.4	13.5	10.4	5.6	5.0	5.6	6.8	2.1	9.0	5.4	5.0	6.9	6.9	5.8	5.2
HPGDS	"GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS"	ENSG00000163106	"Hematopoietic prostaglandin D synthase"	O60760	4	94298535-94342876	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 24.8"	"Group enriched"	"Detected in some"	8	"HEL: 31.6;HMC-1: 9.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"basophil: 15.8"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 15.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA024035	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol			170000	"Vesicles, Cytosol"	Nucleoplasm	"HPA024035: AB_1855743"	"unprognostic (5.71e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.01e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.75e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	14.3	2.9	8.0	1.6	12.1	1.6	5.8	2.0	7.7	5.4	6.9	4.4	0.2	7.5	4.7	3.3	4.1	2.5	9.3	3.0	8.4	3.6	2.5	1.3	12.7	0.9	9.6	2.4	1.5	1.8	1.7	1.5	24.8	9.0	6.4	7.5	2.9	3.8	2.2	1.4	5.8	8.6	5.8	14.6	1.4	4.4	1.8	12.1	1.5	1.2	2.8	1.5	4.5	3.5	0.0	0.1	15.8	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	0.0	0.0	0.0	2.4	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	8.0	12.1	2.0	7.7	8.4	3.6	9.6	2.4	9.0	12.1
HSD3B1	"HSD3B, HSDB3, SDR11E1"	ENSG00000203857	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"	P14060	1	119507198-119515054	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism, Steroidogenesis"	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"placenta: 231.4"	"Cell line enriched"	"Detected in some"	9	"CACO-2: 37.0"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA043261, HPA043264, HPA044028"	Supported		Approved	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"				"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: , HPA043264: , HPA044028: "			"unprognostic (1.53e-1)"				"unprognostic (7.11e-2)"					"unprognostic (1.15e-1)"		"unprognostic (1.04e-1)"			"prognostic favourable (4.59e-5)"	0.1	0.6	0.0	0.0	0.3	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	231.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.5	11.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	4.1	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
HSD3B2	SDR11E2	ENSG00000203859	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"	P26439	1	119414931-119423035	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"adrenal gland: 223.2"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.5;SH-SY5Y: 1.4;SK-MEL-30: 5.1;TIME: 1.2;WM-115: 3.2"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Region enriched"	"Detected in single"	198	"basal ganglia: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA043261, HPA043264, HPA044028"	Supported		Uncertain	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"				"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: , HPA043264: , HPA044028: "	"unprognostic (3.56e-1)"		"unprognostic (1.85e-1)"		"unprognostic (2.80e-1)"		"unprognostic (2.72e-2)"		"unprognostic (8.87e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.55e-1)"			0.0	223.2	0.0	0.8	19.8	0.0	0.0	0.0	0.0	0.0	0.5	43.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	3.6	0.2	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	1.5	1.4	0.0	0.0	5.1	0.0	0.0	1.2	0.2	0.1	0.1	0.7	0.0	0.0	0.0	0.8	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HYI	HT036	ENSG00000178922	"Hydroxypyruvate isomerase (putative)"	Q5T013	1	43451003-43453989	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 130.4;seminal vesicle: 80.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 38.7;WM-115: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.6"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA040092	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA040092: AB_10795374"	"prognostic favourable (9.18e-4)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (4.96e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.86e-1)"	"unprognostic (4.40e-2)"	"prognostic unfavourable (5.55e-4)"	"unprognostic (2.75e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavourable (2.75e-5)"	"unprognostic (5.10e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.58e-2)"	"prognostic favourable (2.72e-5)"	16.5	12.5	11.6	12.1	10.1	5.3	12.8	11.3	9.7	14.6	16.5	13.0	130.4	23.4	15.8	14.8	8.4	15.3	16.7	10.9	9.2	10.0	15.9	25.8	17.8	6.7	10.9	9.3	25.1	34.0	13.8	11.2	10.8	9.0	15.6	7.5	15.0	20.8	80.0	8.8	8.4	22.1	13.4	14.3	7.6	14.1	4.5	11.1	4.9	12.8	9.6	6.4	10.7	11.3	3.2	21.6	6.2	1.2	4.8	5.4	3.0	17.2	2.2	0.7	1.2	3.4	6.3	0.0	15.1	13.5	19.0	12.7	8.8	30.1	0.0	1.1	9.7	3.2	0.0	15.9	7.8	4.2	6.2	2.8	7.9	0.0	22.4	0.0	0.0	3.7	4.6	21.5	0.0	38.7	0.2	0.0	12.7	0.3	2.5	2.9	3.2	4.4	13.3	0.0	0.1	13.2	0.6	8.2	6.1	16.8	9.5	3.7	2.4	21.6	17.8	1.2	0.0	3.4	29.3	0.0	0.0	0.0	1.0	4.0	32.8	6.2	1.1	2.4	3.3	0.9	4.1	3.2	5.4	2.6	4.1	2.7	5.1	1.5	0.1	4.8	1.2	21.6	0.5	3.0	11.6	10.1	11.3	9.7	9.2	10.0	10.9	9.3	9.0	11.1
IDI1		ENSG00000067064	"Isopentenyl-diphosphate delta isomerase 1"	Q13907	10	1039152-1049170	"Enzymes, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039169	Approved									"HPA039169: AB_10674280"	"unprognostic (1.61e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.72e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.72e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.26e-1)"	"prognostic favourable (1.46e-4)"	"unprognostic (9.63e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.61e-2)"	13.6	30.4	23.1	15.2	28.3	47.8	68.8	16.4	39.2	8.8	16.1	22.5	8.0	27.9	7.7	12.6	19.2	6.5	9.9	9.7	23.0	29.2	15.3	67.6	15.6	15.5	21.7	25.3	13.4	13.7	12.3	20.6	10.0	55.9	22.3	15.0	16.9	9.9	7.1	35.1	13.7	17.6	8.3	30.6	17.5	12.9	10.2	14.4	8.5	9.8	16.8	16.3	12.5	11.1	16.1	8.9	36.4	19.6	14.5	18.4	14.8	25.2	9.4	50.5	12.3	21.1	46.2	7.4	10.6	12.0	12.3	26.2	24.8	39.6	22.9	7.0	11.5	22.0	28.0	50.2	11.2	7.8	26.5	22.2	14.2	28.3	24.7	8.5	11.0	29.1	21.1	34.3	4.6	9.6	15.2	32.2	20.7	19.7	16.3	14.1	20.4	5.6	19.1	24.1	25.4	53.5	22.3	7.9	9.5	13.5	27.9	27.8	28.9	28.9	9.6	6.8	3.8	19.8	7.6	18.7	17.6	43.0	8.5	25.5	6.1	36.4	9.4	21.9	18.2	17.1	18.4	16.1	14.2	15.2	8.6	14.9	10.7	15.8	25.1	14.5	19.6	8.9	14.9	14.8	23.1	28.3	16.4	39.2	23.0	29.2	21.7	25.3	55.9	14.4
IDI2	IPPI2	ENSG00000148377	"Isopentenyl-diphosphate delta isomerase 2"	Q9BXS1	10	1018907-1025859	"Enzymes, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	125	"skeletal muscle: 141.6"	"Cell line enhanced"	"Detected in some"		"HEL: 1.3;NB-4: 2.6;NTERA-2: 1.5;SK-MEL-30: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"																														"unprognostic (6.69e-3)"	"unprognostic (4.05e-2)"				"unprognostic (1.64e-1)"				1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	141.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.7	0.5	0.1	0.0	0.7	0.0	0.8	0.1	0.0	1.0	0.0	0.0	0.4	0.4	0.8	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.7	0.0	0.5	0.0	0.3	0.9	1.3	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	2.6	1.5	0.0	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	3.4	1.0	0.1	0.0	0.1	0.1	0.4	0.0	0.2	0.4	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	1.0	0.1	0.1	0.1	0.0	0.7	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ISYNA1	"Ino1, INOS, IPS"	ENSG00000105655	"Inositol-3-phosphate synthase 1"	Q9NPH2	19	18434388-18438301	"Enzymes, Predicted intracellular proteins"	"Inositol biosynthesis, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 83.6"	"Cell line enriched"	"Detected in many"	4	"BEWO: 101.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.0;NK-cells: 11.9;T-cells: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA007931, HPA008232, CAB020720"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB020720: , HPA007931: AB_2667940, HPA008232: AB_2668018"	"unprognostic (1.87e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavourable (9.23e-4)"	"unprognostic (2.23e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.50e-1)"	7.9	8.4	7.1	3.0	5.7	4.5	7.1	2.7	6.7	9.9	3.5	10.0	44.2	3.4	13.9	12.3	4.5	20.0	6.5	8.0	5.7	7.4	12.7	4.1	4.7	3.8	4.1	4.1	31.6	25.5	7.7	12.6	44.2	16.2	9.5	1.3	19.3	8.8	34.4	8.2	3.4	3.9	3.0	2.3	10.5	3.7	83.6	3.5	3.0	5.6	3.8	3.3	5.9	7.8	4.0	1.9	0.9	0.2	11.9	8.5	4.9	2.7	8.4	20.1	5.9	0.1	0.0	101.5	1.3	0.2	0.1	0.0	4.8	5.1	0.0	6.9	0.6	7.2	0.6	0.0	0.0	7.5	23.1	10.1	0.5	15.5	2.1	0.1	0.2	1.6	0.1	0.5	0.1	1.2	20.6	0.4	0.0	16.2	0.7	0.7	10.5	6.8	13.9	0.0	4.7	1.7	0.0	6.2	15.5	0.3	1.9	10.2	13.7	1.1	3.9	0.1	0.2	0.1	0.3	3.2	1.4	0.6	0.6	0.4	3.5	0.9	0.1	0.0	7.6	0.2	5.9	4.0	7.4	6.7	0.7	2.3	6.1	8.5	0.8	11.9	0.1	1.9	5.2	4.9	7.1	5.7	2.7	6.7	5.7	7.4	4.1	4.1	16.2	3.5
LSS	OSC	ENSG00000160285	"Lanosterol synthase"	P48449	21	46188141-46228824	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Isomerase	"Cataract, Disease mutation, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032060, HPA032062, CAB034116"	Supported		Approved	Cytosol				Cytosol		"CAB034116: AB_2138611, HPA032060: AB_10671085, HPA032062: "	"unprognostic (2.78e-3)"	"unprognostic (8.53e-3)"	"unprognostic (6.95e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.34e-2)"	"prognostic unfavourable (6.80e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (3.07e-4)"	21.1	22.9	17.9	9.9	38.8	5.0	14.7	22.5	33.9	11.2	16.9	37.7	5.8	26.4	16.6	12.5	23.4	11.0	12.1	17.8	19.0	17.3	8.4	33.8	19.7	8.3	49.5	14.9	25.7	15.8	10.4	22.7	10.3	42.7	24.0	10.7	13.2	11.0	13.2	24.5	26.2	10.3	12.2	33.3	7.1	14.1	13.8	46.9	6.0	7.5	9.8	8.3	12.3	11.8	4.8	8.0	5.2	3.3	2.7	8.3	5.0	20.0	6.5	21.2	9.0	28.8	27.7	5.9	7.8	55.1	9.6	18.9	21.4	16.0	4.3	6.6	15.0	9.6	18.7	32.5	3.9	4.2	10.0	10.7	10.7	13.8	26.3	3.9	7.5	27.3	12.4	17.9	7.7	7.9	10.4	26.0	8.2	6.8	8.4	5.6	34.5	5.9	10.0	6.5	26.2	24.9	11.1	12.4	11.0	9.1	7.1	8.0	11.3	9.7	11.8	11.4	9.3	10.0	6.0	9.5	8.1	8.7	11.9	17.2	4.9	5.2	3.3	3.5	6.9	3.0	4.7	4.8	5.0	8.3	3.8	3.0	4.2	6.2	0.0	2.7	2.5	8.0	2.3	5.0	17.9	38.8	22.5	33.9	19.0	17.3	49.5	14.9	42.7	46.9
MCEE	GLOD2	ENSG00000124370	"Methylmalonyl-CoA epimerase"	Q96PE7	2	71109684-71130239	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035196			Approved	Nucleoli	"Intracellular and membrane"		16000	Nucleoli		"HPA035196: AB_10601871"	"unprognostic (7.65e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.35e-1)"	"prognostic favourable (4.76e-4)"	"prognostic favourable (5.78e-4)"	"unprognostic (4.86e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.43e-3)"	"unprognostic (8.59e-2)"	"unprognostic (9.40e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.51e-2)"	"unprognostic (5.38e-2)"	10.5	20.4	8.5	10.1	9.2	4.3	18.9	10.5	9.8	14.1	13.8	9.4	24.6	11.1	8.8	19.7	16.9	8.6	12.6	19.8	6.6	6.2	18.8	39.7	9.1	9.5	13.1	6.6	12.4	29.0	9.8	24.5	9.9	9.1	13.7	13.5	11.1	28.9	20.5	18.2	15.2	14.9	10.9	11.5	10.1	13.1	5.7	11.4	9.3	11.0	18.7	10.9	13.0	13.3	15.9	17.6	20.0	18.4	11.2	24.9	11.1	6.3	3.1	5.6	4.0	19.2	26.2	16.4	9.8	12.5	5.0	7.6	7.6	7.9	9.9	3.0	9.7	6.7	6.8	5.1	5.2	9.1	5.9	6.7	8.7	22.0	10.8	7.5	5.6	17.4	7.4	3.4	6.7	5.7	8.8	17.2	4.8	8.1	5.6	8.8	5.2	7.6	6.6	6.4	18.3	7.7	5.1	6.5	4.7	3.7	21.7	9.7	17.2	7.2	7.3	5.9	4.5	5.9	3.9	16.5	6.8	10.5	9.5	12.3	5.3	13.0	18.3	20.0	12.8	18.4	17.3	15.9	15.7	12.3	14.9	13.2	14.6	12.3	4.5	11.2	17.6	17.6	24.9	11.1	8.5	9.2	10.5	9.8	6.6	6.2	13.1	6.6	9.1	11.4
MIF	"GIF, GLIF"	ENSG00000240972	"Macrophage migration inhibitory factor"	P14174	22	23894004-23895227	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Isomerase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 127.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003868, CAB005284"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	13800000	14000000	Cytosol	Nucleoplasm	"CAB005284: AB_648587, HPA003868: AB_1079290"	"unprognostic (1.68e-1)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-1)"	30.6	49.8	43.9	42.0	39.9	46.0	71.6	19.0	66.1	23.0	42.7	10.4	55.6	39.9	22.5	113.3	51.9	23.3	42.5	60.7	42.8	40.3	71.8	58.8	46.2	113.9	33.5	43.7	24.5	80.2	16.2	41.1	30.5	45.2	54.8	11.6	15.0	57.3	101.2	36.0	63.3	50.6	26.7	78.3	42.5	56.2	24.9	19.2	19.0	28.9	43.7	16.7	21.4	44.6	56.8	42.5	17.6	23.8	38.3	52.7	66.0	48.9	10.9	2.4	11.0	0.9	2.2	18.4	18.5	3.1	5.9	7.7	8.1	8.1	23.3	14.7	1.3	21.8	2.5	11.2	0.7	19.6	127.1	8.8	9.9	16.9	4.8	34.0	20.7	4.7	6.7	3.5	1.7	4.7	13.6	11.8	2.0	24.6	23.1	63.0	14.0	59.3	29.7	4.1	65.3	4.6	3.4	31.9	37.2	11.8	12.5	30.5	16.1	10.2	13.5	5.2	35.0	3.1	0.4	51.4	18.1	24.0	21.1	12.7	10.6	16.3	23.8	17.6	37.4	22.3	52.7	56.8	51.8	40.4	31.6	49.1	46.1	38.0	7.1	38.3	14.6	42.5	48.3	66.0	43.9	39.9	19.0	66.1	42.8	40.3	33.5	43.7	45.2	19.2
MPI		ENSG00000178802	"Mannose phosphate isomerase"	P34949	15	74890005-74902219	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007200	Approved		Approved	"Plasma membrane,Cytosol"			170000	Cytosol	"Plasma membrane"	"HPA007200: AB_1854079"	"unprognostic (1.38e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.65e-3)"	"unprognostic (7.34e-2)"	"prognostic unfavourable (2.39e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.58e-2)"	13.6	33.3	24.2	11.2	26.2	7.4	14.7	19.2	33.7	16.7	22.6	26.1	15.3	32.6	15.7	26.8	17.1	20.7	13.4	28.8	22.7	22.2	22.5	30.2	10.6	16.2	28.1	28.3	23.2	34.2	24.7	15.0	11.4	37.4	20.6	23.1	18.3	18.6	17.9	33.3	11.7	27.4	16.4	21.7	14.7	14.3	23.5	17.7	16.4	17.1	15.0	16.6	15.6	11.7	12.8	10.2	2.4	7.4	17.7	27.1	12.9	10.4	14.5	12.0	13.6	27.5	13.4	10.5	9.0	14.8	15.5	21.8	14.3	13.9	14.9	19.7	13.1	26.1	23.8	26.3	14.8	11.3	29.8	26.6	13.8	15.3	19.6	12.2	7.9	17.8	6.8	14.6	26.3	21.0	8.9	12.2	20.0	8.9	13.1	5.4	6.6	12.4	13.5	11.3	36.4	18.2	11.9	22.5	9.8	10.5	19.0	11.3	26.1	8.5	9.5	9.3	8.0	6.9	8.7	30.3	17.9	9.7	19.5	17.8	6.7	0.7	7.2	2.4	13.5	7.4	17.5	12.8	18.3	15.4	10.2	12.5	27.1	19.7	1.1	17.7	6.3	8.5	22.7	12.9	24.2	26.2	19.2	33.7	22.7	22.2	28.1	28.3	37.4	17.7
MRI1	"MGC3207, MRDI, mtnA, Ypr118w"	ENSG00000037757	"Methylthioribose-1-phosphate isomerase 1"	Q9BV20	19	13764532-13774282	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042744, CAB045988"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"			2600000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"CAB045988: AB_2145566, HPA042744: "	"unprognostic (1.16e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.28e-1)"	14.5	18.5	12.5	21.8	18.3	16.6	16.8	24.5	21.8	21.5	17.2	23.6	23.5	19.0	24.2	21.3	20.7	19.9	17.6	13.5	14.6	12.1	24.4	20.1	15.4	19.5	16.5	14.3	24.0	20.5	21.3	17.3	24.2	17.2	17.8	13.4	18.5	23.4	21.6	13.0	28.6	18.5	13.3	16.6	22.0	19.8	5.0	16.7	20.0	21.8	10.5	18.2	18.1	20.6	5.7	8.9	6.9	5.8	5.0	6.6	3.6	10.5	7.9	3.9	9.4	4.3	8.1	9.7	12.6	7.3	11.4	10.4	8.3	8.5	5.7	5.0	4.7	17.9	18.3	13.0	7.0	10.0	31.7	4.5	12.5	8.9	3.8	13.7	10.6	8.1	7.2	5.8	4.6	10.6	8.7	0.3	4.9	15.5	15.1	8.7	6.5	22.5	14.3	5.3	12.9	5.9	8.3	7.9	7.1	4.6	10.3	9.8	8.0	5.0	6.4	5.9	5.5	20.8	6.1	7.8	8.2	1.7	5.0	15.9	7.0	6.9	5.5	1.9	6.2	5.8	6.0	5.0	5.3	6.6	4.7	5.7	4.3	3.3	4.1	5.0	3.2	8.9	4.8	3.6	12.5	18.3	24.5	21.8	14.6	12.1	16.5	14.3	17.2	16.7
MUT		ENSG00000146085	"Methylmalonyl-CoA mutase"	P22033	6	49430360-49463191	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Isomerase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 96.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035971, HPA035972"	Enhanced		Approved	Mitochondria,Cytosol			110000	Cytosol	Mitochondria	"HPA035971: AB_10696648, HPA035972: AB_2674895"	"unprognostic (1.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.89e-2)"	"prognostic favourable (8.71e-13)"	"unprognostic (5.38e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.91e-1)"	10.7	14.3	10.9	5.7	13.4	4.1	9.7	10.0	12.1	8.9	12.7	8.6	9.0	13.6	8.7	8.6	13.2	8.4	7.5	16.6	10.1	10.0	25.5	96.5	7.8	5.7	11.8	9.5	13.1	15.7	15.8	13.5	7.5	12.0	11.2	11.2	8.0	9.3	9.2	13.7	9.0	14.7	11.8	9.7	6.4	10.9	9.1	9.9	8.2	11.2	9.1	5.8	12.8	8.1	9.4	8.9	14.0	15.2	14.2	12.0	6.7	13.2	4.7	14.3	16.6	28.5	27.1	7.9	11.9	15.7	12.6	18.7	5.4	6.9	12.3	9.5	12.7	7.6	15.9	8.4	17.8	10.5	11.5	6.5	10.8	14.2	20.8	8.3	6.3	16.4	12.6	12.8	15.0	12.1	11.9	14.8	14.8	8.3	9.7	8.3	6.1	3.5	8.8	17.9	17.0	14.6	12.8	13.3	9.2	13.1	9.4	19.7	8.2	13.4	8.7	11.8	8.7	15.9	16.0	5.9	6.6	10.6	16.6	9.9	10.2	14.0	7.5	12.5	7.9	9.9	9.9	9.4	9.5	9.9	8.9	8.3	12.0	9.0	4.3	14.2	15.2	6.3	11.9	6.7	10.9	13.4	10.0	12.1	10.1	10.0	11.8	9.5	12.0	9.9
NAXE	"AIBP, APOA1BP, MGC119143, MGC119144, MGC119145, YJEFN1"	ENSG00000163382	"NAD(P)HX epimerase"	Q8NCW5	1	156591762-156594299	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		Isomerase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043766, HPA048164"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"		3300000	Nucleoplasm	Cytosol	"HPA043766: AB_2678660, HPA048164: AB_2680294"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (4.94e-4)"	"unprognostic (7.38e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.08e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.15e-2)"	"unprognostic (8.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-1)"	19.1	29.9	31.6	14.4	28.5	12.1	22.6	17.6	42.5	23.0	30.0	31.0	17.4	28.4	28.5	57.9	23.4	29.4	25.8	46.3	28.5	25.0	41.6	41.0	17.2	16.9	33.2	29.3	29.3	37.3	36.3	29.0	21.8	28.8	27.9	26.6	23.0	29.5	36.3	30.9	20.2	25.9	25.0	29.1	17.4	25.0	29.5	22.2	17.7	32.4	19.5	20.4	20.8	18.3	52.4	53.8	12.4	26.5	31.6	32.5	40.6	31.4	41.8	13.4	23.9	17.8	12.2	16.0	10.9	16.6	18.6	19.7	34.8	21.2	21.4	33.0	13.8	30.7	13.3	26.0	13.2	22.5	29.1	17.7	23.8	22.9	20.4	22.2	18.2	12.3	33.6	23.7	22.1	25.3	18.0	19.5	19.0	56.0	24.4	27.0	16.6	32.7	24.6	12.5	56.5	25.2	26.2	32.3	30.8	26.1	49.8	38.3	48.3	32.7	14.7	13.4	20.9	19.0	23.6	50.6	30.5	20.4	18.5	13.2	20.6	4.9	24.1	12.4	31.6	26.5	31.3	52.4	29.2	32.2	21.7	41.7	32.5	30.9	2.9	31.6	20.6	53.8	25.5	40.6	31.6	28.5	17.6	42.5	28.5	25.0	33.2	29.3	28.8	22.2
NKTR	p104	ENSG00000114857	"Natural killer cell triggering receptor"	P30414	3	42600614-42648741	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022120, HPA051576"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA022120: AB_1854513, HPA051576: "	"unprognostic (2.73e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.27e-3)"	"prognostic favourable (1.26e-4)"	"unprognostic (4.62e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavourable (6.01e-4)"	"prognostic unfavourable (5.02e-4)"	"unprognostic (3.82e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.40e-1)"	"prognostic favourable (1.05e-5)"	12.9	14.4	9.8	18.8	22.2	16.3	15.9	42.0	12.3	18.8	10.4	18.5	15.4	11.8	27.2	17.4	11.0	12.0	13.1	11.2	10.9	10.5	9.5	9.7	14.6	15.5	14.5	11.3	22.7	18.4	19.2	26.9	11.1	14.1	12.9	11.1	20.4	13.2	19.5	12.0	20.0	13.3	19.4	15.0	18.5	10.1	17.8	13.8	20.6	14.9	10.9	19.4	12.9	13.9	9.3	8.5	11.7	10.0	11.1	10.2	3.6	8.9	5.1	17.1	7.0	10.2	12.5	9.6	14.5	3.7	6.0	8.2	9.0	7.2	14.1	7.0	4.4	7.9	10.1	3.6	12.4	7.1	8.4	18.1	16.2	14.5	4.4	13.9	11.9	5.1	7.2	11.9	4.5	10.6	18.2	10.9	11.4	3.7	9.5	13.6	14.7	7.5	10.1	7.7	5.8	8.4	6.8	6.0	3.6	15.6	6.5	2.4	9.5	10.1	17.0	10.9	7.9	11.8	14.0	9.5	13.2	9.8	5.8	17.1	6.6	9.2	6.2	11.7	10.2	7.7	9.4	8.9	9.8	8.5	4.7	9.3	10.0	8.7	9.1	11.1	10.0	8.5	8.3	3.6	9.8	22.2	42.0	12.3	10.9	10.5	14.5	11.3	14.1	13.8
P4HB	"DSI, ERBA2L, GIT, P4Hbeta, PDI, PDIA1, PO4DB, PO4HB, PROHB"	ENSG00000185624	"Prolyl 4-hydroxylase subunit beta"	P07237	17	81843159-81860694	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Chaperone, Isomerase"	"Craniosynostosis, Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 383.4;pancreas: 677.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012463, HPA018884"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted - unknown location"		140000000	"Endoplasmic reticulum"		"CAB012463: , HPA018884: AB_1854896"	"unprognostic (9.47e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.14e-3)"	"unprognostic (7.75e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavourable (2.30e-11)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.19e-3)"	18.0	34.7	6.3	15.4	8.4	35.0	16.1	6.1	6.5	22.1	40.5	9.0	45.0	42.6	14.7	29.1	40.3	12.8	42.3	20.7	6.3	5.9	27.2	383.4	20.9	29.1	7.9	4.5	14.3	677.5	6.4	23.4	58.5	7.2	22.5	8.5	12.3	251.9	42.5	31.0	24.3	112.8	11.0	5.2	36.7	31.6	9.1	7.2	10.5	29.7	50.7	46.4	16.5	20.5	21.6	71.3	45.8	60.8	38.8	55.9	70.8	57.7	50.3	18.6	60.0	50.4	59.3	44.2	112.8	72.8	49.2	66.6	36.9	50.6	23.3	49.6	72.5	41.0	20.5	44.1	28.5	15.0	34.7	34.9	52.9	150.1	66.3	110.1	57.7	44.7	30.0	39.3	41.7	81.0	24.7	100.7	35.0	52.7	31.5	87.5	14.6	45.8	25.8	33.3	46.2	38.2	69.8	22.4	24.8	56.2	162.4	58.5	73.4	129.7	62.9	92.4	46.3	52.4	55.0	72.4	52.4	22.0	121.4	42.4	70.4	45.8	60.8	38.3	53.5	38.7	55.9	21.6	36.4	42.8	43.4	18.7	21.2	31.5	20.0	38.8	27.6	71.3	25.7	70.8	6.3	8.4	6.1	6.5	6.3	5.9	7.9	4.5	7.2	7.2
PDIA2	"PDA2, PDI, PDIP, PDIR"	ENSG00000185615	"Protein disulfide isomerase family A member 2"	Q13087	16	283152-287215	"Enzymes, Predicted intracellular proteins"		"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"pancreas: 286.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.1;HEK 293: 11.3;Hep G2: 8.4;Karpas-707: 3.9;MCF7: 6.0;SH-SY5Y: 4.9"	"Cancer enriched"	"Detected in many"	5	"pancreatic cancer: 28.6"	"Region enhanced"	"Detected in many"		"cerebellum: 15.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA051692, HPA053492"	Enhanced				"Intracellular and membrane"					"HPA051692: AB_2681575, HPA053492: AB_2682169"	"unprognostic (3.46e-2)"	"unprognostic (7.98e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.58e-14)"	"unprognostic (3.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.87e-2)"	0.3	0.3	2.1	0.2	1.5	0.3	0.2	15.3	3.0	0.2	0.7	4.3	0.2	2.9	0.2	0.3	0.2	0.2	0.8	0.4	2.8	3.0	0.2	0.2	0.2	0.2	4.0	0.5	0.4	286.5	0.2	0.2	0.5	2.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	1.0	0.2	5.4	0.2	10.2	0.3	2.8	0.1	0.2	0.2	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	0.1	0.1	5.1	0.2	0.6	0.1	11.3	0.0	0.3	8.4	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.4	3.9	0.2	6.0	0.2	0.6	0.4	0.0	0.1	0.0	1.1	0.0	0.0	2.2	4.9	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	1.5	15.3	3.0	2.8	3.0	4.0	0.5	2.2	2.8
PDIA3	"ERp57, ERp60, ERp61, GRP57, GRP58, HsT17083, P58, PI-PLC"	ENSG00000167004	"Protein disulfide isomerase family A member 3"	P30101	15	43746392-43773279	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002645, HPA003230, CAB011199, CAB015181, CAB075744"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"		390000000	"Endoplasmic reticulum"		"CAB011199: AB_609902, CAB015181: AB_2160857, CAB075744: , HPA002645: AB_1079031, HPA003230: AB_1079030"	"unprognostic (9.20e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.34e-1)"	"prognostic favourable (2.05e-4)"	"unprognostic (2.40e-2)"	"prognostic unfavourable (8.95e-5)"	"unprognostic (1.67e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (2.11e-8)"	"unprognostic (1.82e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.63e-2)"	16.9	21.2	10.0	20.5	13.5	20.8	31.1	12.7	9.2	24.7	19.4	12.3	33.9	22.2	19.7	42.4	21.7	18.4	25.1	20.6	10.2	12.7	27.3	112.5	20.0	34.6	12.4	10.3	22.4	46.8	21.1	21.7	44.0	13.3	24.6	21.2	13.7	43.4	36.9	8.7	17.9	28.8	15.8	11.4	25.2	20.5	17.1	14.3	15.6	74.0	16.4	19.8	14.7	28.3	7.7	18.3	13.5	10.8	11.7	14.1	14.5	12.2	4.6	9.7	21.8	19.8	21.2	29.9	24.6	24.3	18.3	22.7	12.8	12.6	14.0	16.0	28.0	19.5	12.3	23.8	15.9	10.1	18.2	18.9	7.3	11.8	32.5	10.7	13.8	13.6	19.7	13.8	23.3	31.8	10.9	6.9	17.8	4.2	3.6	12.1	9.8	18.6	7.0	15.3	10.5	15.5	10.0	9.8	10.9	20.5	19.7	7.7	13.7	10.9	21.5	15.2	8.0	12.2	11.9	3.1	3.6	14.7	19.5	16.9	11.4	10.0	10.3	13.5	13.4	10.5	14.1	6.5	8.5	10.8	9.6	7.7	7.2	8.4	2.9	11.7	10.8	18.3	6.7	14.5	10.0	13.5	12.7	9.2	10.2	12.7	12.4	10.3	13.3	14.3
PDIA4	"ERP70, ERP72"	ENSG00000155660	"Protein disulfide isomerase family A member 4"	P13667	7	149003062-149028641	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 164.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006139, HPA006140, CAB017368"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"		12000000	"Endoplasmic reticulum"		"CAB017368: AB_10621725, HPA006139: AB_1848256, HPA006140: AB_1848257"	"unprognostic (1.98e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavourable (9.69e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-3)"	"unprognostic (6.08e-3)"	"unprognostic (3.20e-2)"	"prognostic unfavourable (5.20e-9)"	"unprognostic (1.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.51e-1)"	17.6	13.0	7.7	25.6	11.9	7.4	27.4	5.1	7.9	25.5	20.9	12.1	28.8	18.2	19.4	46.3	15.2	20.8	28.1	16.9	7.3	8.0	27.7	164.3	19.1	29.1	11.6	6.2	19.4	76.3	7.0	19.1	24.7	12.0	18.0	21.9	7.8	36.4	26.5	5.8	10.1	21.3	17.8	13.9	27.9	23.7	11.5	11.3	19.2	89.8	11.9	24.3	17.4	22.6	26.6	63.3	16.2	21.2	21.5	35.9	34.5	32.6	31.1	33.8	94.5	30.9	22.1	49.0	46.0	30.8	26.4	43.1	25.8	88.4	23.5	103.3	37.8	21.4	22.8	43.6	23.2	16.7	13.4	11.3	9.0	56.5	41.5	25.7	31.9	21.7	19.6	28.9	23.2	53.5	18.4	64.2	23.1	35.7	24.4	29.3	50.4	18.1	16.1	26.2	57.0	30.8	25.7	10.8	28.4	41.7	30.1	16.0	17.1	19.8	29.2	20.8	11.8	50.5	32.3	48.9	22.0	16.6	48.6	30.4	70.8	16.2	20.1	12.1	34.3	21.2	35.9	26.6	22.6	26.7	19.4	15.1	21.5	22.7	2.7	21.5	21.0	63.3	16.6	34.5	7.7	11.9	5.1	7.9	7.3	8.0	11.6	6.2	12.0	11.3
PDIA5	"FLJ30401, PDIR"	ENSG00000065485	"Protein disulfide isomerase family A member 5"	Q14554	3	123067062-123225227	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 66.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 12.8"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA030353, HPA030355"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"	"Intracellular and membrane"		2900000	"Nucleoplasm, Golgi apparatus"	"Nucleoli fibrillar center"	"HPA030353: AB_10599734, HPA030355: AB_10602200"	"unprognostic (8.81e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-2)"	"prognostic favourable (4.55e-4)"	"unprognostic (4.34e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.26e-3)"	"prognostic unfavourable (8.09e-11)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.06e-3)"	11.6	17.1	2.6	11.2	3.1	6.3	9.3	1.0	4.0	10.0	11.0	2.4	10.9	5.6	12.2	17.1	6.7	9.1	22.2	7.2	2.5	1.2	11.0	66.0	14.4	7.1	2.2	1.8	11.4	18.3	5.2	12.1	29.1	1.9	14.3	10.8	12.7	10.8	7.6	8.1	6.1	8.2	9.5	2.3	8.6	17.6	18.0	2.5	3.2	18.2	5.5	7.9	7.8	6.9	3.2	12.8	0.3	9.0	0.5	2.4	2.3	8.1	5.0	6.3	7.6	28.9	26.2	33.6	15.5	26.0	8.7	24.0	16.0	7.5	0.0	20.3	24.0	4.3	2.7	9.4	9.2	0.2	3.1	3.6	1.5	19.1	12.0	8.9	0.5	22.5	14.2	5.9	12.4	29.4	4.5	21.3	5.9	9.9	2.4	10.5	4.6	5.2	2.3	4.5	22.5	7.3	4.8	6.8	4.1	7.5	8.5	13.3	7.4	11.0	16.3	2.2	7.1	10.5	4.2	6.3	1.6	3.6	7.2	7.1	7.5	0.0	9.0	0.3	1.4	2.2	2.4	3.2	1.0	0.9	5.4	0.8	0.6	0.6	0.2	0.5	0.4	12.8	0.0	2.3	2.6	3.1	1.0	4.0	2.5	1.2	2.2	1.8	1.9	2.5
PDIA6	"ERp5, P5, TXNDC7"	ENSG00000143870	"Protein disulfide isomerase family A member 6"	Q15084	2	10783391-10837977	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034347, HPA034652, HPA034653"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"		53000000	"Endoplasmic reticulum, Cytosol"		"CAB034347: AB_2299360, HPA034652: AB_2674263, HPA034653: AB_10601982"	"unprognostic (8.16e-2)"	"prognostic unfavourable (1.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (1.20e-4)"	"prognostic unfavourable (3.63e-5)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.25e-3)"	"unprognostic (6.03e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavourable (2.51e-6)"	"unprognostic (6.59e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.69e-3)"	26.9	32.7	16.7	25.0	29.9	19.9	28.7	11.3	16.8	33.4	26.1	13.9	53.7	20.4	30.4	76.1	27.1	25.5	22.4	32.7	14.2	13.9	42.1	118.4	30.4	36.3	17.8	12.7	26.5	141.6	24.9	23.3	39.5	19.0	22.6	30.1	14.6	53.4	45.0	15.7	16.1	28.4	26.5	14.3	35.1	30.9	12.4	19.5	18.1	97.9	20.1	29.7	21.9	30.6	45.2	61.0	52.0	46.2	51.5	52.2	59.7	33.9	36.9	52.9	82.9	68.1	58.9	94.0	82.7	76.8	43.4	58.5	52.3	67.1	55.2	58.2	80.8	27.9	39.7	69.2	46.7	43.2	31.3	44.7	28.9	84.9	73.7	45.8	33.6	42.5	53.2	42.0	75.8	97.8	38.4	119.1	42.8	40.2	17.6	47.5	44.1	29.2	42.3	53.9	99.9	61.8	41.1	33.9	67.9	32.6	47.8	46.4	16.9	77.7	48.0	40.8	52.1	36.7	47.8	112.4	69.3	35.8	55.1	57.6	57.0	52.0	44.4	20.5	47.5	46.2	52.2	45.2	37.7	44.7	48.6	33.1	18.4	31.0	8.1	51.5	33.9	61.0	37.7	59.7	16.7	29.9	11.3	16.8	14.2	13.9	17.8	12.7	19.0	19.5
PGAM1	"PGAM-B, PGAMA"	ENSG00000171314	"Phosphoglycerate mutase 1"	P18669	10	97426160-97433441	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042528, HPA060483"	Approved		Approved	Nucleoplasm			200000000	Nucleoplasm		"HPA042528: , HPA060483: "	"prognostic unfavourable (2.04e-4)"	"prognostic unfavourable (3.86e-4)"	"unprognostic (3.64e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.47e-3)"	"unprognostic (7.60e-3)"	"unprognostic (1.74e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.61e-3)"	26.5	46.1	42.8	28.9	50.3	30.2	19.0	32.6	90.0	26.5	27.6	24.9	14.2	29.8	24.3	20.6	63.5	17.7	21.2	54.1	47.4	44.9	32.7	35.7	18.5	29.5	45.7	61.1	22.9	14.3	27.8	23.2	30.8	72.4	21.9	29.2	30.4	24.5	33.7	8.4	30.0	27.4	35.6	25.7	21.7	20.3	26.1	21.0	26.6	17.4	27.0	43.7	31.0	31.9	22.5	49.7	88.0	65.3	22.8	41.2	72.8	120.6	57.4	39.7	75.6	37.6	34.7	54.1	77.4	101.2	91.0	127.0	62.3	36.1	64.0	53.1	65.7	75.8	69.0	112.5	110.4	59.2	65.9	41.3	45.1	69.6	27.8	59.1	55.3	33.9	46.1	60.4	45.1	65.8	27.0	36.3	95.5	49.9	52.8	73.0	60.8	68.9	40.2	36.4	50.7	70.3	45.8	8.6	40.6	41.6	24.9	39.7	67.7	49.9	49.4	48.8	42.9	43.0	88.8	54.7	60.3	58.4	113.4	99.0	22.5	30.4	65.3	88.0	37.0	57.2	32.7	22.5	31.8	36.6	49.7	18.8	20.7	28.9	50.3	22.8	62.8	17.6	41.2	72.8	42.8	50.3	32.6	90.0	47.4	44.9	45.7	61.1	72.4	21.0
PGAM2	PGAM-M	ENSG00000164708	"Phosphoglycerate mutase 2"	P15259	7	44062727-44065587	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 111.6;skeletal muscle: 379.1;tongue: 119.0"	"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 38.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.2;neutrophil: 1.1;plasmacytoid DC: 1.3;T-reg: 1.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.3;granulocytes: 1.2;T-cells: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043801, HPA050314, HPA060173"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol			60000000	Nucleoplasm	"Nucleoli, Cytosol"	"HPA043801: , HPA050314: , HPA060173: "																		1.4	0.8	2.0	0.4	2.2	0.4	0.5	6.9	2.1	0.5	0.5	3.6	0.0	0.6	0.5	9.1	6.1	0.6	0.7	111.6	2.1	3.2	0.8	0.4	0.4	0.4	4.2	1.6	0.5	0.6	0.6	1.3	0.4	2.0	1.9	0.4	2.3	7.6	0.5	379.1	0.4	0.4	0.4	3.2	0.5	0.5	16.7	1.1	4.8	1.5	119.0	4.8	0.4	0.0	0.3	1.3	1.2	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	38.1	4.2	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	1.3	1.7	0.2	2.0	2.2	6.9	2.1	2.1	3.2	4.2	1.6	2.0	1.1
PGAM4	"dJ1000K24.1, PGAM-B, PGAM1, PGAM3"	ENSG00000226784	"Phosphoglycerate mutase family member 4"	Q8N0Y7	X	77968874-77969638	"Enzymes, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 5.3"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA042528, HPA060483"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA042528: , HPA060483: "	"unprognostic (3.10e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.52e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.76e-3)"	0.9	2.1	0.9	2.6	1.5	3.0	0.4	0.8	2.1	1.9	0.6			2.4	1.4	0.7	2.9	1.3	0.0	1.3	1.0	1.5	0.9	1.2	0.4	1.2	1.5		1.0	0.1	0.7	0.7	0.7		0.5	0.7		0.6	0.2	1.1	0.8	2.0	1.3	0.4	1.0	1.3	0.5			0.3		0.7	1.6	1.2	0.7	1.9	3.7	2.4	0.8	1.6	3.5	5.3	3.1	0.3	0.9	0.4	0.0	2.7	0.5	0.1	0.6	0.8	0.0	0.5	0.8	1.4	0.3	2.3	0.2	0.0	0.7	0.6	0.3	0.0	1.1	0.7	0.0	1.6	0.9	0.4	0.2	0.2	0.0	0.5	0.0	0.6	0.8	0.9	2.6	3.9	1.1	0.7	0.8	0.9	2.0	0.0	0.7	0.1	2.6	0.3	0.0	1.3	1.0	0.6	0.0	1.0	1.8	1.6	3.0	2.7	1.4	0.7	3.7	1.5	0.5	0.6	2.4	3.7	1.4	2.2	1.1	0.7	1.1	1.3	1.9	0.7	0.6	0.9	1.5	0.8	2.1	0.5	1.6	3.5										
PGM1		ENSG00000079739	"Phosphoglucomutase 1"	P36871	1	63593276-63660245	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase	"Congenital disorder of glycosylation, Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 233.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004666, HPA024190, HPA024637, HPA046329"	Enhanced		Approved	Cytosol			20000000	Cytosol		"CAB004666: AB_425590, HPA024190: AB_1855266, HPA024637: AB_1855267, HPA046329: "	"unprognostic (2.50e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (8.74e-5)"	"unprognostic (7.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.74e-3)"	17.8	14.1	7.0	4.4	8.3	3.5	9.8	4.4	8.3	6.7	12.9	5.2	4.6	10.6	4.6	7.7	8.8	3.3	8.9	36.9	6.4	5.4	10.0	56.4	7.6	2.7	6.2	6.3	9.7	21.6	12.9	6.2	11.5	8.5	8.7	9.1	5.4	7.9	9.4	233.5	5.3	12.4	8.4	5.6	3.0	5.7	3.0	5.5	3.0	6.0	42.8	6.3	9.4	4.7	12.2	25.9	25.6	17.9	21.1	23.3	16.6	30.2	12.7	4.8	15.7	31.7	23.4	38.9	12.5	17.0	13.6	22.3	10.5	14.1	9.6	26.2	19.2	7.2	6.6	26.3	16.1	11.7	8.8	20.2	21.5	10.8	26.2	17.7	1.2	29.5	17.0	15.9	25.2	8.1	0.0	12.8	21.8	1.8	5.1	9.7	21.8	20.4	7.2	22.3	3.1	19.8	9.5	2.9	18.7	27.3	28.6	41.6	8.9	6.7	0.8	20.2	10.3	17.9	10.6	8.1	11.9	15.6	33.0	15.6	8.6	20.5	17.9	25.6	23.3	12.0	18.6	12.2	13.7	17.5	25.9	6.9	12.5	14.5	21.2	21.1	10.2	7.5	10.6	16.6	7.0	8.3	4.4	8.3	6.4	5.4	6.2	6.3	8.5	5.5
PGM2	FLJ10983	ENSG00000169299	"Phosphoglucomutase 2"	Q96G03	4	37826633-37862937	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040676	Uncertain		Approved	"Intermediate filaments"			1900000	"Intermediate filaments"		"HPA040676: AB_2677076"	"unprognostic (3.11e-2)"	"unprognostic (1.01e-2)"	"prognostic favourable (2.14e-5)"	"unprognostic (2.29e-1)"	"unprognostic (3.94e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.09e-3)"	"unprognostic (5.32e-2)"	"unprognostic (7.02e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.02e-1)"	11.2	10.8	7.7	11.6	5.9	7.5	13.5	9.8	5.7	14.7	10.3	4.2	6.5	6.1	15.0	7.6	41.3	7.0	11.0	8.3	7.1	4.0	11.1	13.3	7.5	13.2	4.4	5.7	10.0	9.0	9.5	6.4	27.9	10.4	11.1	8.4	6.8	11.0	5.0	2.4	17.7	8.6	12.2	6.9	13.4	9.0	9.0	3.9	17.3	8.8	31.7	22.9	13.6	18.9	4.5	15.3	30.8	13.1	13.2	7.0	7.2	11.5	4.0	6.2	6.6	4.7	5.2	8.1	13.9	8.2	11.4	11.8	7.1	8.4	15.2	6.9	7.6	6.0	15.0	13.0	29.2	9.7	8.7	16.7	6.7	5.0	10.1	17.5	11.7	7.5	15.8	9.4	8.4	18.3	21.7	2.7	10.0	6.1	19.9	20.7	7.1	6.3	15.2	9.8	6.3	7.1	22.3	13.0	4.4	7.0	10.3	4.9	8.9	18.8	15.9	8.6	10.6	11.6	28.2	6.2	16.1	17.3	4.5	23.0	14.4	8.0	13.1	30.8	4.9	10.5	5.8	4.5	4.1	5.6	15.3	2.8	4.0	5.0	16.3	13.2	8.0	3.4	7.0	7.2	7.7	5.9	9.8	5.7	7.1	4.0	4.4	5.7	10.4	3.9
PGM3	"AGM1, DKFZP434B187, PAGM"	ENSG00000013375	"Phosphoglucomutase 3"	O95394	6	83161150-83193936	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004998, HPA029759, HPA029760"	Enhanced		Approved	Nucleoplasm,Cytosol			73000	"Nucleoplasm, Cytosol"		"CAB004998: AB_425591, HPA029759: AB_10600305, HPA029760: AB_10601109"	"prognostic unfavourable (8.78e-4)"	"prognostic unfavourable (5.67e-4)"	"unprognostic (1.45e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.09e-3)"	"unprognostic (6.72e-3)"	"unprognostic (3.11e-1)"	"prognostic favourable (9.96e-4)"	"unprognostic (4.00e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (2.39e-7)"	"unprognostic (2.21e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.22e-3)"	15.5	16.7	11.2	10.4	13.7	4.8	12.3	19.1	13.3	15.4	10.1	9.0	30.7	8.9	10.6	26.2	10.3	8.8	14.2	12.2	11.0	8.6	12.2	44.9	13.4	6.3	13.5	9.9	15.5	36.3	9.3	36.2	27.6	18.1	30.9	13.7	7.4	29.2	23.4	5.5	7.5	11.6	11.1	9.7	8.1	14.4	16.8	11.3	4.0	14.9	7.6	8.7	11.1	10.0	8.2	7.4	11.1	6.5	5.3	8.7	3.9	10.0	6.6	12.9	15.4	21.0	22.4	14.9	34.3	24.9	16.6	26.2	17.2	4.7	5.3	7.3	34.2	6.4	11.7	14.4	31.9	3.9	11.4	6.8	13.1	28.8	23.8	6.6	3.4	14.2	11.9	29.3	37.1	19.5	22.1	5.8	17.9	10.4	1.1	4.4	5.7	9.1	4.7	28.8	3.1	12.9	9.9	5.1	8.0	9.9	8.8	6.8	7.7	7.4	28.5	11.5	6.3	23.0	18.4	11.3	4.4	3.8	9.0	5.3	17.9	11.1	6.4	3.8	5.0	6.0	6.7	8.2	5.2	6.2	5.5	5.0	8.7	8.2	2.7	5.3	6.5	7.4	3.6	3.9	11.2	13.7	19.1	13.3	11.0	8.6	13.5	9.9	18.1	11.3
PIN1	dod	ENSG00000127445	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 1"	Q13526	19	9835257-9849682	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 88.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB004528, CAB009326, HPA068650, HPA070887"	Approved		Enhanced	Nucleoplasm,Cytosol			30000	Nucleoplasm	Cytosol	"CAB004528: AB_628132, CAB009326: AB_2237080, HPA068650: , HPA070887: "	"unprognostic (2.54e-1)"	"unprognostic (6.14e-3)"	"unprognostic (6.50e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.23e-3)"	"prognostic favourable (3.25e-4)"	"unprognostic (9.43e-2)"	"prognostic favourable (7.80e-5)"	"unprognostic (2.20e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.21e-2)"	24.5	36.3	40.0	18.7	38.8	25.6	9.3	27.4	66.0	9.2	15.8	18.1	8.5	22.9	14.0	8.3	11.3	16.4	10.1	25.9	38.0	35.2	17.4	14.5	13.2	14.8	38.7	37.2	13.9	21.1	9.5	13.6	13.3	57.3	23.2	6.5	14.1	21.3	15.7	50.2	10.2	21.7	11.1	19.6	15.4	19.6	24.8	15.0	19.7	9.9	8.1	9.3	11.1	9.7	36.4	72.8	88.2	44.9	40.7	53.8	46.2	25.9	23.8	17.8	16.5	6.2	5.6	10.5	19.4	8.4	14.5	14.0	22.1	8.3	16.1	31.0	7.2	13.3	12.2	11.7	4.6	34.3	52.0	41.8	29.3	19.0	10.1	19.5	24.6	7.6	7.9	9.4	4.4	11.8	18.9	24.5	8.7	18.2	29.5	76.2	17.0	36.6	27.0	18.5	27.0	10.4	12.8	22.4	26.4	18.7	9.4	21.7	12.0	23.4	19.9	20.1	16.1	31.1	31.1	31.6	29.7	21.7	21.5	25.0	24.7	52.2	43.4	88.2	42.0	44.9	39.2	35.6	41.5	42.1	39.7	36.4	33.1	37.2	26.8	40.7	41.7	72.8	53.8	46.2	40.0	38.8	27.4	66.0	38.0	35.2	38.7	37.2	57.3	15.0
PIN4	"EPVH, PAR14, PAR17"	ENSG00000102309	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 4"	Q9Y237	X	72181353-72302926	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 68.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054483, HPA064504"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA054483: , HPA064504: AB_2685274"	"unprognostic (2.47e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.14e-2)"	"prognostic favourable (6.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.92e-1)"	"prognostic favourable (2.58e-4)"	"unprognostic (3.34e-3)"	"prognostic favourable (2.66e-4)"	14.4	11.3	15.0	8.0	14.7	6.1	18.8	10.7	16.2	9.7	9.7	8.4	6.7	9.5	11.6	19.3	8.9	8.7	30.7	11.2	15.2	12.2	15.6	23.2	7.9	7.9	12.9	11.0	12.7	8.1	8.0	9.2	9.8	10.0	10.4	11.1	6.6	30.7	37.1	68.7	7.3	9.6	9.2	12.4	16.7	9.3	4.7	6.9	9.7	12.9	40.1	9.1	7.8	9.2	28.9	26.8	23.4	23.6	22.4	33.4	22.7	15.1	17.8	18.6	12.7	12.8	10.7	9.9	10.4	11.9	12.8	13.1	9.0	11.3	4.6	30.4	10.7	10.8	16.5	18.3	15.8	11.5	37.1	7.8	21.2	23.4	7.1	12.3	6.6	7.2	10.1	13.9	4.8	12.9	13.1	20.2	9.5	18.3	10.7	20.7	13.3	16.1	10.7	14.8	13.4	16.2	10.6	11.9	21.3	12.2	5.7	10.7	8.8	11.2	13.0	5.8	8.9	15.9	7.5	6.9	7.5	7.6	16.7	12.3	6.3	21.9	23.3	23.4	26.8	23.6	26.4	28.9	28.3	25.5	22.8	26.4	29.3	29.4	9.7	22.4	21.8	26.8	33.4	22.7	15.0	14.7	10.7	16.2	15.2	12.2	12.9	11.0	10.0	6.9
PMM1	Sec53	ENSG00000100417	"Phosphomannomutase 1"	Q92871	22	41576894-41589890	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030712, HPA074950"	Uncertain		Supported	Cytosol				Cytosol		"HPA030712: AB_10669600, HPA074950: "	"unprognostic (2.66e-1)"	"prognostic favourable (5.92e-4)"	"unprognostic (3.25e-2)"	"prognostic favourable (6.09e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.78e-1)"	"prognostic favourable (2.05e-4)"	"unprognostic (6.56e-3)"	"unprognostic (5.76e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.70e-1)"	20.8	25.1	24.3	15.2	28.8	15.3	15.0	15.5	27.9	24.7	29.5	12.6	14.1	25.3	12.1	20.1	36.5	24.8	14.7	17.7	19.6	20.6	32.8	32.2	21.7	10.8	20.3	25.5	34.8	30.5	7.7	8.7	9.7	17.8	13.7	13.9	11.8	13.0	17.3	6.6	13.6	22.0	14.3	15.2	6.0	24.5	27.6	13.2	8.8	8.9	12.7	14.7	15.2	13.2	10.6	13.2	24.5	12.7	6.8	27.1	10.3	5.2	9.8	6.7	14.4	19.4	30.2	7.8	21.0	24.0	19.4	21.4	7.8	5.1	4.9	7.0	25.0	7.9	8.8	13.6	10.9	10.3	13.4	1.2	12.3	16.4	30.7	7.4	8.1	25.1	13.2	20.1	8.4	3.1	5.4	17.8	26.3	13.9	5.6	10.7	2.1	13.2	4.3	7.2	10.2	8.2	5.7	1.9	3.8	17.1	6.1	25.1	7.0	8.2	2.4	22.0	12.1	20.4	10.7	11.2	10.7	7.9	24.5	6.2	13.2	9.6	12.7	24.5	16.3	10.2	13.8	10.4	16.8	13.8	13.2	10.6	18.3	12.9	16.6	6.8	12.0	5.0	27.1	10.3	24.3	28.8	15.5	27.9	19.6	20.6	20.3	25.5	17.8	13.2
PMM2	"CDG1, CDG1a, CDGS, PMI, PMI1"	ENSG00000140650	"Phosphomannomutase 2"	O15305	16	8788823-8849331	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"basophil: 52.2"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 52.2"	"Low region specificity"	"Detected in all"							"HPA040852, HPA063649"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040852: AB_10794069, HPA063649: AB_2685074"	"unprognostic (8.62e-3)"	"unprognostic (8.00e-3)"	"prognostic favourable (1.04e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.14e-3)"	"unprognostic (2.62e-1)"	"prognostic unfavourable (8.97e-6)"	"unprognostic (1.22e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.02e-2)"	14.8	13.1	6.8	15.4	9.0	4.3	13.6	8.2	8.2	11.4	19.4	7.0	11.6	18.9	9.7	13.1	22.7	10.0	13.9	10.7	4.7	2.9	14.6	43.3	11.8	11.2	6.6	4.3	7.8	40.4	7.8	28.3	19.9	6.6	12.0	20.4	8.8	21.2	13.5	12.5	13.2	19.6	9.5	5.7	12.0	15.2	9.7	7.8	7.6	10.0	12.0	22.0	10.5	12.2	2.9	3.5	52.2	4.9	1.6	3.6	3.0	10.9	24.5	5.4	14.2	9.7	15.3	12.1	17.1	20.7	17.2	18.6	18.3	13.6	17.5	7.2	29.8	15.2	11.1	20.9	17.6	13.0	13.0	5.8	14.8	31.2	18.4	15.3	13.9	22.8	14.9	18.3	16.9	17.5	7.8	17.1	11.4	28.7	15.6	14.1	23.0	15.9	19.9	12.1	34.8	19.1	19.4	10.3	19.5	14.1	31.1	10.2	20.2	13.4	20.3	12.4	14.0	33.4	16.7	21.2	17.7	22.0	10.3	19.3	16.4	52.2	4.9	0.9	2.5	3.7	3.6	2.9	2.2	3.2	3.5	2.4	2.5	2.4	7.8	1.6	2.3	3.2	1.6	3.0	6.8	9.0	8.2	8.2	4.7	2.9	6.6	4.3	6.6	7.8
PPIA	CYPA	ENSG00000196262	"Peptidylprolyl isomerase A"	P62937	7	44796680-44824564	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB004655, HPA058345"	Uncertain				"Secreted to blood"		420000000			"CAB004655: AB_425607, HPA058345: "	"unprognostic (3.10e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.86e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavourable (2.27e-6)"	"unprognostic (1.12e-3)"	"unprognostic (3.30e-2)"	"unprognostic (3.92e-2)"	"unprognostic (8.68e-3)"	"unprognostic (2.52e-1)"	"unprognostic (6.35e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.16e-1)"	92.0	90.3	147.0	80.4	124.3	105.9	169.0	88.9	148.0	111.3	143.5	81.6	52.9	73.9	74.8	125.1	176.5	76.3	80.4	60.2	132.0	121.9	149.2	214.3	95.4	137.1	123.2	88.3	74.2	103.2	93.1	58.3	96.2	142.5	83.0	149.1	68.1	84.7	102.3	68.4	114.7	105.1	113.9	120.8	137.0	73.1	62.4	59.8	228.2	130.2	123.4	191.2	94.3	93.1	129.8	158.5	35.0	83.1	76.0	117.7	180.3	85.8	115.3	146.5	106.3	122.8	186.7	48.3	125.9	197.8	241.9	237.4	127.9	131.7	194.2	64.9	160.3	117.5	188.3	241.1	223.2	111.0	137.3	78.4	132.9	121.8	99.6	158.9	81.9	136.6	165.6	171.4	188.4	245.6	161.1	157.1	248.7	122.3	174.1	281.4	167.2	159.0	125.1	88.7	247.0	328.0	121.5	109.7	90.9	106.1	304.4	82.7	163.2	217.0	109.1	124.7	120.3	83.4	165.0	114.7	226.4	327.7	108.7	180.9	188.0	23.4	74.5	35.0	94.9	83.1	102.0	129.8	97.0	97.1	134.8	103.9	80.3	88.2	9.2	76.0	77.7	158.5	117.7	180.3	147.0	124.3	88.9	148.0	132.0	121.9	123.2	88.3	142.5	59.8
PPIAL4A	"COAS2, PPIAL4, PPIAL4B"	ENSG00000263353	"Peptidylprolyl isomerase A like 4A"	Q9Y536	1	120889746-120890405	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 3.5;intestine: 1.6"	"Cell line enhanced"	"Detected in many"		"NB-4: 4.5;SK-BR-3: 4.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA058345	Uncertain									"HPA058345: "	"unprognostic (3.49e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.74e-1)"	0.3	0.8		1.0		1.4	0.2		1.2	0.0	0.0			1.6	0.0	0.0	0.0	0.0	0.0	0.1			0.2	1.2	0.0	0.5			0.1	0.0	0.0		0.4		0.0	0.0		0.0	0.0	0.0	0.2	1.0	0.0		0.4	0.4	0.0			0.0		0.0	0.0		3.0	3.2	0.6	1.6	2.2	2.4	3.5	0.9	0.0	0.1	1.4	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	1.0	0.7	0.2	0.0	1.7	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.8	0.0	0.0	0.3	0.2	3.7	0.3	0.6	1.7	4.5	2.4	0.0	0.8	1.5	1.9	0.0	0.0	1.0	0.3	0.3	4.6	0.4	3.0	2.5	0.7	3.0	1.2	2.9	1.6	1.3	0.9	2.4	2.6	1.5	3.1	0.2	1.6	0.6	1.4	1.2	1.4	3.0	2.3	2.4	3.1	2.2	1.5	2.4	0.0	2.2	1.2	3.2	2.4	3.5										
PPIAL4C		ENSG00000263464	"Peptidylprolyl isomerase A like 4C"	A0A0B4J2A2	1	149583865-149584464	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 10.9;intestine: 5.5"	"Cell line enhanced"	"Detected in many"		"NB-4: 14.2;THP-1: 16.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA058345	Uncertain									"HPA058345: "	"unprognostic (3.16e-1)"	"unprognostic (2.83e-2)"			"unprognostic (1.50e-2)"	"unprognostic (7.93e-2)"		"unprognostic (5.98e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-1)"				"unprognostic (6.61e-2)"			"unprognostic (2.25e-1)"	0.0	3.3		2.7		0.1	0.0		1.5	0.0	0.8			5.5	0.8	0.0	0.0	0.0	0.0	0.0			1.0	0.0	1.0	2.9			0.2	0.0	0.9		0.7		0.3	0.0		0.0	0.0	0.2	0.5	2.9	0.0		1.4	0.9	0.0			0.0		0.3	0.0		9.1	9.7	1.9	6.0	4.6	7.8	10.9	3.5	0.3	0.4	3.1	0.1	0.3	2.0	0.5	0.4	1.0	0.7	0.0	4.8	1.2	2.1	0.0	3.9	0.0	0.2	0.6	3.5	0.0	0.5	0.0	0.0	0.1	2.0	1.9	0.1	0.5	0.6	0.3	0.0	0.9	5.3	0.7	0.4	5.2	14.2	6.1	0.1	5.2	0.0	8.9	0.2	0.0	3.9	5.4	1.1	11.1	6.0	5.2	16.6	1.2	3.5	5.5	3.3	8.0	4.2	5.5	9.0	3.8	4.6	7.7	0.9	4.3	1.9	5.4	6.0	6.0	9.1	6.1	5.7	9.4	7.2	5.0	5.9	0.0	4.6	5.3	9.7	7.8	10.9										
PPIAL4D		ENSG00000256374	"Peptidylprolyl isomerase A like 4D"	F5H284	1	145241630-145242124	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	4	"blood: 5.4;brain: 3.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.1;NB-4: 1.9;SK-MEL-30: 1.7;THP-1: 1.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA058345	Uncertain									"HPA058345: "					"unprognostic (9.32e-2)"					"unprognostic (1.33e-1)"				"unprognostic (3.05e-2)"				0.0	0.0	0.5	0.0	0.7	0.0	0.0	3.9	0.5	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.6	0.2	0.7	0.0		0.0	0.0	0.0	0.0	0.7		0.0	0.5		0.0	0.0	0.0	0.5	0.1	0.0	0.2	1.0	0.0	0.0			0.2		0.0	0.0	0.0	4.5	3.8	0.7	3.7	1.8	4.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.0	0.9	0.0	0.9	0.4	0.0	0.0	0.0	1.7	0.6	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.7	1.4	0.3	1.2	3.7	1.4	4.5	2.7	1.7	3.6	3.1	2.8	3.5	0.0	1.8	1.8	3.8	4.1	5.4										
PPIAL4E		ENSG00000271567	"Peptidylprolyl isomerase A like 4E"	A0A075B759	1	144372875-144373659	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 3.4;bone marrow: 2.7;skeletal muscle: 1.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.1;HL-60: 1.3;NB-4: 1.4;SK-BR-3: 2.1;TIME: 2.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA058345	Uncertain									"HPA058345: "					"unprognostic (6.97e-2)"					"unprognostic (5.22e-2)"				"unprognostic (2.28e-1)"				0.0	0.4		0.0		2.7	0.0		0.0	0.0	0.0			0.6	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.1	0.0			0.0	0.7	0.0		0.0		0.0	0.0		0.0	0.0	1.8	1.1	0.4	0.0		0.0	0.0	0.0			0.0		0.0	0.0		1.7	0.6	1.9	2.0	3.4	2.9	0.6	0.6	0.5	0.5	0.1	0.0	0.0	0.4	0.2	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.0	2.0	0.1	0.6	0.3	0.0	0.6	0.4	0.2	0.0	0.2	0.0	0.0	2.0	1.0	2.9	0.5	1.9	1.3	1.6	1.3	0.5	1.7	0.5	0.5	1.9	3.4	1.5	0.6	0.8	0.6										
PPIAL4F		ENSG00000279782	"Peptidylprolyl isomerase A like 4F"	P0DN26	1	144592868-144593527	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058345	Uncertain									"HPA058345: "					"unprognostic (1.08e-1)"					"unprognostic (2.22e-2)"				"unprognostic (2.02e-1)"				0.0	0.0		0.0		0.0	0.6		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.9	0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0										
PPIAL4G		ENSG00000236334	"Peptidylprolyl isomerase A like 4G"	P0DN37	1	148479824-148483679	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"brain: 6.9;skeletal muscle: 6.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA058345	Uncertain									"HPA058345: "		"unprognostic (2.17e-3)"			"unprognostic (3.63e-1)"	"unprognostic (4.83e-1)"		"unprognostic (2.26e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.11e-1)"		"unprognostic (3.95e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.79e-1)"				0.2	0.1	1.3	0.7	1.8	1.3	0.3	6.9	1.2	0.1	0.2			0.5	0.4	1.0	0.3	0.1	0.3	0.2	0.9	1.1	0.1	0.2	0.2	1.1	0.5		0.4	0.0	0.1	0.3	0.1		0.2	0.3		0.4	0.0	6.8	0.8	0.7	0.0	0.4	2.7	0.5	0.5			0.4		0.3	0.0	0.0	2.2	0.6	2.4	0.8	2.4	3.2	0.2	0.8	1.1	0.5	1.7	0.2	0.3	1.3	0.3	0.3	0.1	0.1	1.3	0.9	1.2	0.8	0.3	1.0	0.1	0.2	0.2	0.5	0.6	1.2	2.4	1.0	0.1	1.5	1.1	0.2	1.8	0.1	0.3	0.2	0.7	1.8	0.0	0.9	0.8	2.5	1.1	0.3	0.6	0.3	0.8	0.3	1.3	0.7	0.9	1.0	0.7	0.4	1.1	1.3	0.8	0.9	0.9	1.4	0.7	1.4	1.2	1.0	0.7	1.0	0.9	2.2	0.4	1.0	3.2	0.4	2.4	0.9	1.5	1.7	0.3	2.2	1.6	2.8	2.4	2.4	0.8	0.6	0.5	0.2										
PPIB	"CYPB, OI9"	ENSG00000166794	"Peptidylprolyl isomerase B"	P23284	15	64155812-64163205	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Isomerase, Rotamase"	"Disease mutation, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011487, HPA012720"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Secreted to blood"		120000000	"Endoplasmic reticulum"	Nucleoplasm	"CAB011487: AB_443295, HPA012720: AB_1847399"	"unprognostic (3.00e-3)"	"unprognostic (5.65e-3)"	"unprognostic (2.81e-1)"	"prognostic favourable (1.56e-5)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.79e-2)"	"prognostic unfavourable (2.02e-11)"	"unprognostic (7.05e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-2)"	56.9	64.3	23.9	49.3	26.9	54.9	48.1	15.1	32.1	75.3	44.1	35.4	102.8	42.0	64.2	106.9	48.0	54.8	58.1	44.5	23.8	27.3	89.5	285.9	57.2	63.8	29.7	19.6	67.5	193.7	26.7	71.8	120.2	27.5	51.0	47.7	36.2	123.3	95.4	19.5	33.1	57.5	54.3	30.7	78.0	47.7	27.2	29.5	53.7	154.3	45.7	69.1	49.2	51.7	63.5	191.6	41.0	51.1	44.9	71.6	87.1	39.3	49.5	44.7	101.6	156.7	91.0	39.3	94.0	123.5	74.4	88.5	71.2	73.1	37.6	76.4	145.5	64.2	81.7	63.1	38.4	23.8	30.8	53.0	54.7	93.1	164.3	52.9	48.0	83.8	68.1	43.4	105.8	89.8	37.0	131.0	56.4	62.8	16.1	81.1	39.0	31.8	30.9	47.5	191.8	77.2	61.4	25.3	39.9	43.0	74.0	68.4	44.2	161.8	55.2	74.4	61.7	41.6	63.4	71.2	68.9	39.5	69.5	85.2	74.2	41.0	51.1	33.9	71.6	39.2	71.5	63.5	50.5	58.1	67.4	38.0	33.0	44.2	25.5	44.9	25.2	191.6	40.1	87.1	23.9	26.9	15.1	32.1	23.8	27.3	29.7	19.6	27.5	29.5
PPIC	CYPC	ENSG00000168938	"Peptidylprolyl isomerase C"	P45877	5	123023250-123036741	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039163	Approved				"Intracellular and membrane"		5700000			"HPA039163: "	"unprognostic (7.81e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.49e-2)"	"prognostic unfavourable (4.78e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.43e-2)"	22.5	13.7	3.3	10.8	3.6	0.0	29.9	1.6	4.2	24.3	30.0	3.6	26.6	15.7	20.4	32.7	35.5	9.0	25.8	43.7	4.0	2.7	27.4	24.0	16.3	9.0	3.7	2.1	13.3	24.3	8.7	5.8	28.3	10.0	17.8	22.0	5.3	25.9	18.0	18.4	12.0	35.2	37.9	5.4	8.9	13.5	8.0	3.2	2.5	42.7	29.6	12.9	31.5	21.5	0.0	1.1	0.0	0.1	0.0	0.3	0.0	4.6	4.1	1.6	33.8	58.8	27.0	6.7	13.3	10.4	6.9	14.3	6.8	31.7	0.0	23.7	35.8	5.3	4.6	16.8	5.6	0.0	8.1	6.7	15.4	7.8	15.1	0.0	3.7	16.9	12.9	8.1	8.6	14.3	1.8	0.0	4.9	27.8	0.0	0.0	2.9	7.1	0.0	3.6	0.0	21.9	16.3	2.1	3.7	26.1	12.7	2.8	17.8	14.9	15.8	13.4	8.4	4.6	5.7	0.0	0.0	0.0	11.6	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.3	0.0	3.3	3.6	1.6	4.2	4.0	2.7	3.7	2.1	10.0	3.2
PPID	CYP-40	ENSG00000171497	"Peptidylprolyl isomerase D"	Q08752	4	158709134-158723396	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Protein transport, Transport"	"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019520, HPA019692"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoli, Cytosol"	Nucleoplasm	"HPA019520: AB_1847400, HPA019692: AB_1847401"	"unprognostic (4.26e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.91e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.72e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.09e-1)"	16.8	25.8	20.1	15.5	21.4	14.9	22.3	26.7	26.8	12.6	16.8	14.4	18.2	33.4	14.6	13.6	16.5	15.4	13.0	28.8	19.4	22.1	21.5	45.3	11.0	17.4	22.6	18.9	14.6	17.5	11.3	30.3	14.5	26.0	16.1	14.2	9.1	15.4	13.7	53.3	24.0	29.2	13.1	22.7	16.5	15.5	16.9	23.4	22.7	21.7	16.0	16.8	15.4	55.0	15.6	17.2	33.4	22.2	23.9	24.4	17.1	15.3	14.3	14.4	19.7	21.4	16.1	21.8	15.2	8.3	14.0	10.6	18.5	10.5	16.2	6.8	14.1	11.8	43.6	17.4	17.1	53.7	15.2	29.0	12.9	25.5	16.6	18.2	21.8	10.1	14.2	12.0	17.9	15.2	36.2	29.0	15.5	14.7	26.0	16.5	19.8	19.1	11.8	7.1	13.9	15.4	7.7	24.4	16.3	11.4	23.7	21.6	10.9	17.4	14.7	14.0	15.8	15.4	20.0	16.7	34.6	20.7	17.8	19.7	14.0	33.4	15.3	33.2	21.2	22.2	24.4	14.6	20.7	19.6	16.7	15.6	21.5	22.0	20.9	23.9	22.0	17.2	22.4	17.1	20.1	21.4	26.7	26.8	19.4	22.1	22.6	18.9	26.0	23.4
PPIE	"CyP-33, MGC111222, MGC3736"	ENSG00000084072	"Peptidylprolyl isomerase E"	Q9UNP9	1	39692182-39763914	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, RNA-binding, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA019357, HPA020131"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA019357: , HPA020131: AB_1847405"	"unprognostic (2.94e-1)"	"unprognostic (4.32e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.99e-2)"	"unprognostic (8.41e-2)"	"prognostic unfavourable (1.76e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.29e-2)"	"prognostic unfavourable (5.05e-5)"	"unprognostic (5.86e-2)"	"unprognostic (3.95e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.00e-1)"	19.3	23.8	23.7	24.3	22.5	18.6	25.7	25.9	36.1	25.5	28.1	35.6	22.2	19.7	30.6	26.5	26.0	34.7	21.1	27.1	22.3	22.1	25.2	29.8	20.6	25.9	26.3	20.5	35.5	42.1	27.4	23.6	21.9	24.9	26.1	22.7	26.9	30.7	28.9	29.6	21.7	23.2	34.2	25.6	25.7	23.9	38.8	20.2	22.8	33.7	21.9	33.9	31.5	22.6	43.3	31.6	14.1	27.2	49.0	46.9	44.2	9.6	16.7	15.4	12.3	17.1	15.2	8.1	16.6	16.7	25.4	23.9	20.8	28.5	27.4	23.5	18.6	14.7	21.0	24.7	24.3	17.7	22.6	30.2	19.4	6.3	23.5	27.2	16.6	13.8	22.6	23.8	8.8	22.8	30.6	19.2	18.5	17.3	12.5	22.1	18.4	18.7	18.6	11.6	15.6	19.2	18.0	21.9	17.5	17.4	14.2	12.0	17.8	71.5	14.8	16.0	17.7	19.7	25.5	26.3	26.3	18.9	11.1	35.1	25.0	11.6	27.1	14.1	38.3	27.0	37.0	43.3	39.7	38.2	31.6	39.8	46.9	38.9	2.2	49.0	27.2	28.5	40.0	44.2	23.7	22.5	25.9	36.1	22.3	22.1	26.3	20.5	24.9	20.2
PPIF	"Cyp-D, hCyP3"	ENSG00000108179	"Peptidylprolyl isomerase F"	P30405	10	79347469-79355337	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Necrosis"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 32.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077416			Supported	Mitochondria			27000000	Mitochondria		"HPA077416: "	"unprognostic (2.21e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.72e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.16e-3)"	"unprognostic (3.45e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.82e-1)"	"unprognostic (9.37e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.88e-2)"	16.5	76.2	12.1	15.7	18.8	52.0	16.9	7.1	21.3	8.3	18.1	27.1	13.2	13.3	5.2	7.6	21.0	8.8	10.0	36.5	13.0	14.5	21.0	73.1	9.4	19.4	23.3	16.6	7.2	42.0	12.0	6.2	11.3	25.2	6.6	19.9	7.5	12.7	21.9	44.4	22.5	11.1	9.9	28.0	19.6	34.0	20.8	18.0	8.8	10.0	73.9	19.8	12.5	11.0	8.0	18.6	32.8	14.9	3.6	5.0	6.5	35.1	15.0	10.5	20.7	9.8	12.8	13.5	20.5	27.0	45.2	42.8	35.0	17.1	36.6	11.4	14.4	21.1	32.6	19.1	70.5	11.6	30.7	57.3	14.7	61.6	16.7	39.4	13.6	30.0	13.8	44.8	44.9	7.9	55.7	45.2	15.3	18.1	10.2	33.0	8.8	83.4	17.6	16.3	18.7	17.5	32.9	21.0	15.6	10.5	42.7	15.8	18.7	30.5	7.1	19.8	18.0	23.3	39.5	21.0	21.3	29.6	19.6	51.4	5.3	5.1	14.9	7.3	4.7	11.4	5.0	8.0	4.2	4.3	18.6	3.9	3.8	3.7	32.8	3.6	4.1	2.3	4.2	6.5	12.1	18.8	7.1	21.3	13.0	14.5	23.3	16.6	25.2	18.0
PPIG	"CARS-Cyp, SCAF10, SRCyp"	ENSG00000138398	"Peptidylprolyl isomerase G"	Q13427	2	169584340-169641406	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021788, HPA057469"	Supported		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA021788: AB_1847408, HPA057469: "	"unprognostic (2.70e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.55e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.15e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (4.56e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.39e-2)"	26.2	25.3	28.5	23.8	45.3	39.2	26.7	45.0	40.7	33.1	27.1	14.6	26.0	25.3	27.1	28.1	29.4	24.3	21.2	24.2	30.0	20.3	26.0	41.1	25.5	30.4	27.7	35.9	29.5	22.8	39.4	56.7	26.0	38.0	29.3	23.9	13.8	28.6	28.8	27.8	24.5	30.8	31.9	39.7	29.7	24.1	19.8	33.7	24.1	28.4	22.6	29.9	37.4	27.6	36.4	23.7	41.7	24.7	18.7	29.6	13.3	19.1	9.1	25.8	14.1	14.3	17.6	24.3	21.9	16.5	16.2	16.8	24.9	22.1	33.1	20.2	15.8	18.5	20.2	18.0	24.0	23.0	16.3	49.8	13.6	30.3	13.8	46.8	22.2	14.8	20.4	22.0	24.7	17.8	48.0	27.6	18.5	15.5	34.5	28.7	37.0	9.3	31.8	25.8	32.3	20.1	28.9	22.6	14.9	23.6	17.6	23.8	16.4	27.1	20.4	21.2	16.2	14.1	18.0	16.1	23.1	46.2	15.6	25.1	19.4	20.7	20.0	29.9	20.3	20.1	23.2	27.6	27.0	23.8	14.9	36.4	29.6	23.7	41.7	18.7	24.7	23.7	22.9	13.3	28.5	45.3	45.0	40.7	30.0	20.3	27.7	35.9	38.0	33.7
PPIH	"CYP-20, CYPH, MGC5016, SnuCyp-20, USA-CYP"	ENSG00000171960	"Peptidylprolyl isomerase H"	O43447	1	42658425-42676758	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059019	Approved									"HPA059019: "	"unprognostic (7.93e-3)"	"unprognostic (5.49e-3)"	"unprognostic (2.53e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavourable (1.55e-5)"	"unprognostic (1.09e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.40e-2)"	"prognostic unfavourable (1.78e-9)"	"unprognostic (6.59e-3)"	"unprognostic (4.93e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	17.5	19.7	20.4	35.7	19.6	40.7	21.4	23.9	23.3	19.5	24.0	20.9	14.7	18.0	29.8	24.2	29.6	19.2	14.4	21.2	18.0	16.1	17.5	13.6	17.8	31.0	15.8	19.9	22.0	17.7	7.0	15.2	24.6	17.2	17.1	26.5	19.2	24.4	18.8	18.4	20.9	20.7	20.8	15.0	27.2	18.0	21.1	18.6	39.7	26.9	28.1	36.8	15.3	20.3	20.0	14.9	16.8	12.3	18.5	26.3	14.0	18.9	12.2	15.5	21.7	5.1	9.7	20.9	12.9	9.2	24.2	22.2	19.3	21.7	31.4	16.3	9.6	15.5	28.2	19.8	25.5	26.4	22.7	29.8	22.6	17.9	4.4	57.1	17.5	6.3	10.5	22.6	17.6	11.2	36.9	17.9	11.9	15.9	44.3	80.5	38.1	14.7	24.8	28.9	27.9	11.6	12.4	12.2	22.1	11.4	18.9	14.2	10.4	83.7	9.3	10.7	27.4	14.6	30.9	11.6	26.9	57.1	11.9	53.5	17.5	12.6	8.8	16.8	21.0	12.3	19.8	20.0	21.7	23.9	11.7	19.2	22.3	26.3	1.8	18.5	11.2	14.9	20.2	14.0	20.4	19.6	23.9	23.3	18.0	16.1	15.8	19.9	17.2	18.6
PPIL1	CYPL1	ENSG00000137168	"Peptidylprolyl isomerase like 1"	Q9Y3C6	6	36854827-36875024	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA062916			Approved	Nucleoli				Nucleoli		"HPA062916: "	"unprognostic (3.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.81e-2)"	"prognostic unfavourable (1.28e-5)"	"unprognostic (2.01e-1)"	"unprognostic (3.37e-2)"	"prognostic favourable (4.90e-4)"	"unprognostic (6.58e-2)"	"unprognostic (5.49e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.15e-2)"	9.0	17.2	15.9	11.1	23.1	7.3	12.3	16.6	18.7	11.1	10.2	13.0	5.7	8.7	13.7	11.7	13.1	17.5	7.5	29.7	13.2	19.8	17.6	34.3	7.5	13.4	15.0	15.5	13.2	36.7	10.6	19.4	16.0	15.3	11.2	13.2	11.0	12.0	12.5	11.7	5.6	8.2	17.4	15.8	10.3	8.5	14.0	11.0	10.2	23.5	13.4	17.4	12.2	8.1	7.7	6.6	1.1	4.4	5.0	15.0	6.9	14.1	11.2	29.6	19.7	4.0	8.4	16.0	14.4	9.6	21.7	18.1	19.6	9.4	21.7	18.3	10.1	11.5	35.0	24.0	24.9	18.1	29.2	25.8	7.3	25.9	13.2	22.0	10.8	6.3	11.4	16.7	31.3	19.4	48.3	10.6	15.7	13.4	26.1	10.1	19.6	15.2	21.1	25.9	19.5	12.9	10.0	31.5	16.6	9.6	10.3	18.9	15.0	18.7	11.8	16.8	15.5	12.8	24.0	11.6	30.3	39.7	5.3	40.8	31.9	1.1	3.2	0.8	11.2	4.4	15.0	7.7	9.3	10.7	6.6	6.2	10.5	12.3	0.9	5.0	2.1	5.6	6.8	6.9	15.9	23.1	16.6	18.7	13.2	19.8	15.0	15.5	15.3	11.0
PPIL2	"CYC4, Cyp-60, UBOX7"	ENSG00000100023	"Peptidylprolyl isomerase like 2"	Q13356	22	21666009-21700015	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"K-562: 69.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035344, HPA055637"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA035344: AB_10672863, HPA055637: "	"unprognostic (1.97e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.90e-3)"	"unprognostic (5.16e-3)"	"unprognostic (3.77e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-3)"	"unprognostic (5.46e-2)"	"unprognostic (5.39e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.54e-3)"	15.0	21.5	19.4	20.9	24.6	16.6	13.5	24.1	30.9	17.7	17.4	25.3	19.1	18.6	21.8	17.0	22.3	15.7	16.5	20.0	17.2	17.1	21.2	20.3	14.6	23.7	15.6	20.9	16.6	31.4	23.6	30.2	31.4	19.0	19.5	17.6	23.6	22.0	16.5	25.5	17.5	19.1	15.2	15.0	21.3	19.5	18.4	17.6	32.8	27.0	13.6	33.5	17.4	16.2	8.7	11.7	4.8	17.3	12.8	13.2	9.1	6.5	6.8	8.0	8.4	8.1	7.0	7.2	8.6	6.1	10.5	9.0	6.9	4.3	11.2	5.2	9.5	9.6	10.6	7.3	6.3	6.9	10.8	10.5	6.8	8.1	5.9	16.5	9.9	7.5	6.6	7.5	5.7	9.0	69.7	8.1	7.5	10.2	7.4	4.5	7.6	4.2	9.6	11.8	2.3	5.3	6.6	12.4	6.8	7.8	12.4	2.8	8.9	5.5	10.9	6.6	10.7	7.7	5.4	9.4	6.8	8.5	7.5	6.3	7.9	1.0	8.6	4.7	9.5	13.9	11.4	7.0	11.1	12.0	11.7	8.7	9.8	8.9	4.8	12.8	17.3	11.1	13.2	9.1	19.4	24.6	24.1	30.9	17.2	17.1	15.6	20.9	19.0	17.6
PPIL3	CyPJ	ENSG00000240344	"Peptidylprolyl isomerase like 3"	Q9H2H8	2	200870907-200889303	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040765, HPA062187"	Approved		Supported	Nucleoplasm			35000	Nucleoplasm		"HPA040765: , HPA062187: "	"unprognostic (8.96e-3)"	"unprognostic (6.07e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.31e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.40e-2)"	"prognostic favourable (1.19e-4)"	"unprognostic (5.23e-2)"	"unprognostic (6.60e-2)"	"prognostic unfavourable (5.16e-4)"	"unprognostic (1.14e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.87e-2)"	12.4	17.9	18.1	15.5	19.2	24.2	21.1	20.1	20.2	19.4	16.4	18.4	21.1	12.7	17.2	24.3	25.4	19.1	15.9	17.6	17.5	21.8	15.9	19.4	15.9	23.7	20.0	11.8	31.4	16.7	11.9	17.4	15.5	23.0	19.5	16.6	16.3	13.8	15.8	13.4	14.7	15.7	16.8	23.2	20.2	15.7	18.2	13.0	26.3	23.7	19.4	25.5	28.6	13.6	23.4	21.7	18.7	14.1	20.6	20.6	10.7	7.9	7.1	22.0	9.5	17.3	37.1	7.2	12.8	13.8	14.7	14.9	5.2	15.2	7.6	13.5	13.7	10.5	7.6	15.5	13.2	16.2	18.5	32.4	19.9	35.0	8.9	31.0	16.5	13.4	15.3	12.0	19.1	9.8	25.6	18.8	18.8	12.7	23.8	24.7	13.4	11.4	9.0	12.3	12.1	19.4	12.4	9.1	8.5	12.9	12.2	20.5	10.2	14.1	13.3	21.3	12.0	12.6	10.5	20.6	19.5	36.1	16.2	13.9	13.4	18.7	12.7	12.7	12.7	10.8	18.5	23.4	15.6	13.7	21.7	18.9	19.1	20.6	3.0	20.6	14.1	17.9	20.1	10.7	18.1	19.2	20.1	20.2	17.5	21.8	20.0	11.8	23.0	13.0
PPIL4		ENSG00000131013	"Peptidylprolyl isomerase like 4"	Q8WUA2	6	149504733-149546038	"Enzymes, Predicted intracellular proteins"		"Isomerase, RNA-binding, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031599, HPA031600"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA031599: AB_2673950, HPA031600: AB_10600928"	"unprognostic (6.12e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.85e-2)"	"unprognostic (8.42e-2)"	"unprognostic (7.53e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.91e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.94e-2)"	20.0	20.1	20.6	15.0	35.5	30.6	21.2	35.1	27.8	24.0	15.3	19.7	10.1	14.1	21.1	27.2	15.7	18.0	19.8	18.3	21.3	15.6	18.8	23.0	17.9	15.7	20.9	18.0	32.9	16.0	20.8	36.6	22.6	23.9	20.5	16.8	15.7	18.2	16.7	14.8	15.4	16.0	20.0	22.7	17.6	16.0	15.9	19.4	27.0	26.8	8.2	16.8	22.0	19.2	21.4	16.6	24.9	17.8	28.7	24.6	14.8	10.9	5.9	20.7	17.1	12.3	16.2	19.3	21.7	20.7	23.7	25.4	12.4	11.3	11.6	15.0	16.7	10.0	15.8	8.3	37.7	16.8	14.9	12.8	13.0	21.3	19.4	23.3	10.9	12.6	14.2	24.2	20.3	12.9	27.8	7.0	18.4	11.7	13.2	20.0	16.3	9.3	17.9	19.1	5.8	18.0	8.4	12.2	9.4	25.8	11.3	14.7	13.3	17.0	15.1	15.7	12.4	27.8	20.6	9.3	4.7	18.2	13.3	18.7	22.7	24.9	16.1	18.1	14.7	17.8	20.4	21.4	19.5	16.9	16.6	16.6	24.6	18.7	13.4	28.7	16.1	16.2	20.7	14.8	20.6	35.5	35.1	27.8	21.3	15.6	20.9	18.0	23.9	19.4
PPIL6	"bA425D10.6, dJ919F19.1, MGC41939, RSPH12"	ENSG00000185250	"Peptidylprolyl isomerase like 6"	Q8IXY8	6	109390215-109441171	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 36.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.6;ASC diff: 10.6;ASC TERT1: 13.2;hTCEpi: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036717, HPA058165"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA036717: AB_10671969, HPA058165: "	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.32e-1)"	1.5	1.4	5.5	1.1	8.6	0.7	3.6	5.0	4.8	4.6	1.7	7.2	7.4	1.9	3.8	12.7	2.0	36.5	1.7	2.6	6.0	5.4	4.9	1.2	8.9	1.1	3.4	3.2	6.3	4.3	6.6	7.6	1.6	18.3	1.8	1.6	2.6	2.8	5.0	3.9	1.7	1.1	5.4	3.2	1.3	2.3	20.4	5.3	0.0	17.2	1.4	1.1	2.9	2.0	5.1	1.7	2.0	1.3	1.7	1.3	1.1	1.8	1.1	1.2	6.6	10.6	13.2	1.2	0.0	2.4	0.6	0.2	0.1	1.8	0.0	0.5	0.6	1.2	1.0	0.0	0.4	0.5	0.9	0.5	0.1	0.0	5.3	0.6	0.3	2.7	6.3	0.2	4.0	0.8	0.9	0.4	0.4	0.6	0.1	0.6	0.2	1.3	0.8	0.0	0.6	5.1	0.1	1.5	2.5	0.2	0.3	4.4	0.5	1.0	0.4	0.1	0.2	1.1	0.2	0.3	0.1	0.1	2.2	0.1	0.4	2.0	1.2	1.2	0.9	1.3	0.9	5.1	1.2	1.1	1.7	3.2	1.1	1.0	1.6	1.7	1.1	1.7	1.3	1.1	5.5	8.6	5.0	4.8	6.0	5.4	3.4	3.2	18.3	5.3
PPWD1	KIAA0073	ENSG00000113593	"Peptidylprolyl isomerase domain and WD repeat containing 1"	Q96BP3	5	65563236-65587549	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019353, HPA019360"	Enhanced		Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA019353: AB_1855668, HPA019360: AB_1855669"	"unprognostic (3.31e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.85e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavourable (2.19e-4)"	"unprognostic (1.37e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.72e-2)"	"prognostic unfavourable (6.72e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	17.5	15.8	24.3	23.5	26.1	26.0	18.9	28.3	29.7	21.3	16.5	17.9	16.8	15.0	22.0	20.9	17.3	20.4	17.1	14.9	20.0	12.6	14.2	17.3	16.3	28.7	20.9	18.3	26.0	18.6	22.7	26.9	20.9	20.9	18.7	21.5	13.1	16.6	17.7	18.0	23.7	21.2	16.9	19.3	28.9	17.8	19.1	21.1	32.4	19.5	15.2	26.7	16.7	23.7	15.6	13.5	18.1	12.3	15.4	23.3	14.5	19.7	13.1	19.6	18.9	17.3	21.4	20.9	19.2	13.7	20.7	26.0	19.7	19.6	22.4	15.3	13.8	17.6	21.2	19.7	28.1	18.7	18.5	13.9	20.5	17.2	15.0	12.9	14.6	17.0	8.1	19.9	14.2	17.8	18.9	15.8	16.4	19.9	19.8	16.3	13.8	7.7	18.5	26.2	18.9	12.1	16.7	10.0	7.9	18.9	8.2	17.1	12.0	17.0	13.5	11.4	16.0	12.3	28.1	9.0	13.4	23.5	12.5	19.0	12.1	18.1	10.1	16.7	17.2	11.1	20.7	15.6	18.9	18.7	13.5	12.3	23.3	20.4	8.2	15.4	12.3	7.8	20.7	14.5	24.3	26.1	28.3	29.7	20.0	12.6	20.9	18.3	20.9	21.1
PTGDS	"L-PGDS, PGDS"	ENSG00000107317	"Prostaglandin D2 synthase"	P41222	9	136975092-136981742	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism, Transport"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 286.6;retina: 331.2"	"Group enriched"	"Detected in some"	6	"HHSteC: 103.8;HSkMC: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	27	"plasmacytoid DC: 140.9"	"Lineage enriched"	"Detected in many"	27	"dendritic cells: 140.9"									"HPA004938, CAB009916"	Approved				"Secreted to blood"		4300000000			"CAB009916: AB_2174617, HPA004938: AB_1855745"	"unprognostic (2.79e-2)"	"unprognostic (3.96e-3)"	"unprognostic (9.70e-2)"	"unprognostic (5.71e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (1.19e-7)"	"unprognostic (8.49e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.21e-2)"	34.1	27.9	138.1	37.5	159.8	2.5	11.3	61.5	154.6	260.4	10.5	192.5	23.0	6.4	22.5	130.0	26.0	72.4	65.8	286.6	121.0	85.2	22.3	6.0	39.7	114.8	170.8	130.6	7.0	20.0	1.8	20.6	38.5	118.8	78.5	4.2	331.2	18.8	149.8	17.0	19.7	11.2	18.6	188.0	50.1	13.5	218.5	103.2	3.3	3.4	4.3	51.1	49.5	75.8	0.0	140.9	0.2	0.1	0.3	5.2	1.0	0.0	0.0	0.0	0.0	1.0	3.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	4.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	103.8	0.0	0.2	50.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.1	13.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	5.2	0.1	0.3	0.0	0.4	0.6	0.1	0.0	0.1	1.1	0.2	0.3	0.0	140.9	0.1	1.0	138.1	159.8	61.5	154.6	121.0	85.2	170.8	130.6	118.8	103.2
PTGES	"MGST-IV, MGST1-L1, MGST1L1, PIG12, TP53I12"	ENSG00000148344	"Prostaglandin E synthase"	O14684	9	129738331-129753047	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 59.8;placenta: 51.7;seminal vesicle: 182.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 31.0;BEWO: 32.9;HaCaT: 43.0;SK-BR-3: 31.6;U-2197: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 16.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045064	Enhanced		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA045064: AB_10795889"	"unprognostic (2.92e-3)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (2.32e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (7.97e-5)"	"unprognostic (2.22e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.20e-2)"	17.0	0.6	1.1	6.2	1.7	3.0	16.7	1.1	1.8	11.9	4.2	0.8	59.8	1.2	2.0	9.1	8.7	2.7	4.1	4.2	2.1	3.5	3.9	0.4	3.5	3.1	1.3	0.7	2.7	0.6	6.3	0.7	51.7	2.1	11.2	2.0	2.9	16.3	182.9	2.5	19.8	3.7	4.8	1.4	1.3	3.4	9.9	0.6	2.3	1.7	6.6	14.1	14.5	15.0	0.0	0.1	16.8	3.2	0.0	0.0	0.1	0.2	19.3	0.0	9.2	31.0	10.7	32.9	1.4	12.7	0.2	0.3	0.9	14.1	0.0	0.5	3.5	43.0	0.1	1.4	0.1	0.0	0.1	0.0	13.7	0.0	0.7	0.0	0.0	6.3	10.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	1.7	0.0	0.0	0.0	1.0	20.6	0.1	0.7	17.2	31.6	0.1	16.5	0.0	0.1	0.0	0.0	81.7	0.0	0.0	0.0	0.0	16.2	0.0	0.1	16.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	3.2	0.0	0.0	0.1	1.1	1.7	1.1	1.8	2.1	3.5	1.3	0.7	2.1	0.6
PTGES2	"C9orf15, FLJ14038"	ENSG00000148334	"Prostaglandin E synthase 2"	Q9H7Z7	9	128120693-128128462	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020631, HPA020733"	Approved		Approved	Mitochondria				Mitochondria		"HPA020631: AB_1855887, HPA020733: "	"unprognostic (1.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.33e-2)"	"prognostic favourable (5.83e-7)"	"unprognostic (2.10e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"	9.3	17.0	16.5	9.2	17.8	4.4	7.4	15.3	24.1	7.1	14.8	9.9	7.6	17.7	8.1	9.0	12.6	8.4	10.0	36.4	17.4	14.0	13.2	13.0	5.8	10.2	14.2	11.6	9.2	18.3	11.7	14.3	10.7	10.5	8.0	7.0	13.2	16.2	12.0	73.5	9.3	13.2	5.9	7.0	9.5	14.3	5.8	9.8	9.3	10.5	16.2	13.3	8.5	7.3	5.2	8.2	1.2	6.3	3.7	6.5	2.9	12.6	35.4	3.9	14.7	3.6	3.7	12.1	9.7	5.4	12.3	6.6	26.4	19.8	11.2	15.5	3.9	32.9	5.7	12.0	1.7	8.0	15.4	5.7	26.8	24.6	11.0	11.6	11.5	5.0	8.7	9.9	6.8	8.4	12.6	7.0	4.0	39.1	13.8	22.1	12.6	28.7	10.5	7.9	28.5	8.4	9.5	19.8	11.8	14.0	22.4	9.4	20.0	6.2	11.0	12.6	15.7	17.0	17.6	16.1	7.8	10.9	9.6	9.0	11.7	1.2	6.0	1.0	5.6	6.3	6.5	5.2	3.7	5.9	6.7	4.5	4.3	5.1	1.1	3.7	2.8	8.2	4.2	2.9	16.5	17.8	15.3	24.1	17.4	14.0	14.2	11.6	10.5	9.8
PTGES3	"cPGES, p23, TEBP"	ENSG00000110958	"Prostaglandin E synthase 3"	Q15185	12	56663341-56688408	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 358.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034319, HPA038672, HPA038673"	Enhanced		Approved	Nucleoplasm,Cytosol			580000	Cytosol	Nucleoplasm	"CAB034319: AB_2175206, HPA038672: AB_10697395, HPA038673: AB_10670786"	"prognostic unfavourable (2.15e-5)"	"unprognostic (2.60e-1)"	"unprognostic (8.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-3)"	"prognostic unfavourable (4.44e-6)"	"unprognostic (4.33e-3)"	"unprognostic (3.64e-2)"	"prognostic favourable (4.36e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.07e-1)"	44.7	41.4	56.0	41.2	55.7	39.6	175.0	44.2	51.7	49.0	51.9	38.1	49.5	46.4	57.7	52.0	52.6	69.8	36.0	46.0	54.6	57.2	52.1	67.1	46.4	62.0	67.0	41.4	82.3	55.1	43.2	49.2	50.3	57.0	60.7	55.3	24.0	36.6	49.4	64.2	37.0	46.7	64.7	72.5	42.7	36.6	39.7	65.1	53.5	72.5	36.7	55.1	72.7	358.9	40.6	36.9	27.3	74.8	29.2	42.5	60.5	79.9	69.8	56.6	33.7	41.7	37.9	86.3	52.4	40.1	67.5	50.5	59.1	84.4	88.7	79.7	44.7	51.6	106.1	68.5	85.6	65.1	70.6	69.2	44.1	68.2	30.6	82.2	50.3	27.4	50.1	51.0	61.9	69.4	111.0	85.0	65.9	49.9	81.6	78.1	96.7	81.5	71.4	53.4	119.0	59.4	62.6	73.4	42.9	53.5	77.2	45.4	88.9	69.1	41.6	40.6	47.2	48.7	72.4	35.8	98.6	71.3	44.2	67.9	73.0	27.3	37.5	23.2	32.0	59.0	42.0	40.6	42.5	38.1	36.9	28.5	42.3	36.4	14.8	29.2	74.8	31.3	42.5	60.5	56.0	55.7	44.2	51.7	54.6	57.2	67.0	41.4	57.0	65.1
PTGIS	"CYP8A1, PGIS"	ENSG00000124212	"Prostaglandin I2 synthase"	Q16647	20	49503874-49568146	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Isomerase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 88.2"	"Group enriched"	"Detected in some"	4	"ASC diff: 17.4;ASC TERT1: 17.5;U-2197: 53.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009517, HPA014193, HPA052244"	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB009517: AB_2173209, HPA014193: AB_1855746, HPA052244: "	"unprognostic (7.68e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.45e-2)"	"unprognostic (5.22e-2)"	"prognostic unfavourable (4.74e-8)"	"unprognostic (2.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.89e-3)"	"prognostic unfavourable (9.99e-5)"	18.2	2.5	0.6	8.0	1.3	0.1	28.3	0.2	1.6	23.3	14.6	0.5	6.5	1.7	36.5	21.7	13.2	32.0	36.3	23.8	0.3	0.5	3.0	3.8	7.5	1.6	0.5	0.9	51.2	1.3	0.2	0.5	1.0	1.0	27.2	3.7	3.2	3.7	4.6	7.0	3.2	4.4	88.2	1.4	0.3	8.7	16.2	0.3	0.0	6.7	5.6	1.7	64.2	36.1	1.0	0.8	2.7	0.6	0.8	0.5	0.1	0.0	0.0	0.7	0.0	17.4	17.5	0.2	0.3	2.1	0.0	0.0	0.0	0.0	0.0	6.9	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	53.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.6	0.4	0.4	0.4	0.3	0.4	0.3	0.3	0.1	1.0	0.4	0.5	2.7	0.8	0.3	0.8	0.2	0.1	0.6	1.3	0.2	1.6	0.3	0.5	0.5	0.9	1.0	0.3
PTPA	"PPP2R4, PR53"	ENSG00000119383	"Protein phosphatase 2 phosphatase activator"	Q15257	9	129110950-129148946	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005695, CAB022068, CAB035999"	Approved		Enhanced	Nucleoplasm,Cytosol			4800000	Nucleoplasm	Cytosol	"CAB022068: , CAB035999: , HPA005695: AB_1855658"	"unprognostic (4.97e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.13e-2)"	"prognostic favourable (6.50e-5)"	"unprognostic (1.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.65e-2)"	"unprognostic (6.44e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	16.5	35.1	41.6	19.8	41.2	18.1	23.9	32.0	74.2	27.5	27.4	27.2	30.1	18.3	26.7	26.0	31.8	30.1	28.7	42.1	38.0	32.4	32.6	41.0	22.1	19.8	30.8	35.5	23.2	22.4	55.0	22.5	21.4	37.0	33.4	21.7	20.8	36.0	41.5	110.7	27.2	18.8	35.3	21.9	24.4	23.8	62.4	17.6	23.7	27.2	37.0	21.3	22.1	23.9	12.6	19.2	7.8	15.5	17.7	18.4	14.9	24.8	44.1	27.2	50.4	18.4	22.6	27.2	26.0	29.5	35.8	25.0	23.6	30.7	25.9	19.7	44.1	40.5	28.4	32.1	30.8	46.0	15.5	16.0	46.7	22.4	54.8	27.6	34.8	27.0	31.7	26.1	24.9	36.4	23.7	28.8	30.0	64.5	25.1	17.1	42.7	43.9	25.1	25.1	47.6	37.5	31.2	29.5	20.9	52.7	54.4	32.5	57.7	12.0	26.7	29.7	26.9	30.6	36.7	26.3	67.3	23.4	36.6	18.0	40.9	5.8	15.5	7.8	18.4	15.5	17.6	9.6	14.0	16.4	19.2	12.6	13.1	13.1	5.4	17.7	14.4	13.8	14.0	14.9	41.6	41.2	32.0	74.2	38.0	32.4	30.8	35.5	37.0	17.6
PUS1		ENSG00000177192	"Pseudouridylate synthase 1"	Q9Y606	12	131929200-131945896	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051636, HPA057593"	Approved		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA051636: , HPA057593: "	"unprognostic (2.72e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.69e-2)"	"unprognostic (8.12e-3)"	"unprognostic (8.07e-2)"	"unprognostic (4.57e-3)"	"unprognostic (7.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.30e-2)"	"prognostic unfavourable (3.49e-8)"	"unprognostic (1.80e-3)"	"unprognostic (8.06e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.56e-2)"	12.7	15.8	18.8	19.5	23.3	26.2	11.2	8.8	16.9	8.7	11.9	9.4	11.0	12.4	13.6	18.7	16.5	12.9	25.1	8.6	15.6	8.3	10.7	22.8	11.0	21.4	11.7	15.8	10.1	19.8	7.2	9.5	8.3	11.7	11.7	10.5	7.6	11.4	15.7	13.5	15.4	13.9	9.7	6.2	17.4	13.6	11.9	16.4	11.6	10.3	11.6	15.8	10.8	12.8	5.9	4.6	1.9	2.0	9.1	4.0	1.3	15.2	20.0	4.7	8.4	4.6	7.9	29.2	11.8	5.0	9.0	5.8	22.1	10.0	18.3	13.7	6.4	19.4	15.6	11.2	5.9	8.1	31.6	18.4	9.7	19.3	12.4	31.4	16.9	7.9	9.1	10.3	8.8	8.8	22.8	5.6	5.2	26.6	20.6	28.2	25.1	30.5	19.7	6.8	18.9	7.3	21.3	13.3	7.4	9.9	13.6	10.9	14.9	34.0	7.7	7.2	15.4	15.3	17.1	15.5	11.6	21.7	7.4	25.2	9.9	1.2	2.0	0.4	3.2	1.4	2.2	5.9	2.7	3.3	1.6	5.5	4.0	2.1	1.9	9.1	1.3	4.6	2.4	1.3	18.8	23.3	8.8	16.9	15.6	8.3	11.7	15.8	11.7	16.4
PUS10	"CCDC139, FLJ32312"	ENSG00000162927	"Pseudouridylate synthase 10"	Q3MIT2	2	60940222-61018259	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044736, HPA049582"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"				"Nucleoplasm, Nuclear bodies, Mitochondria"		"HPA044736: AB_2679066, HPA049582: "	"unprognostic (1.90e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.44e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-4)"	"unprognostic (1.07e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.15e-3)"	7.0	8.7	7.4	5.0	7.3	3.9	7.3	6.8	7.9	4.8	10.0	5.1	3.0	9.2	7.7	9.1	5.0	5.4	6.4	4.6	6.5	6.9	8.5	17.6	6.3	6.5	8.5	4.6	6.8	7.2	6.3	10.3	4.2	5.9	6.6	6.0	6.7	6.2	3.9	6.7	4.3	19.8	3.6	7.1	5.9	4.2	7.8	8.0	9.1	10.4	4.1	8.3	4.4	4.4	5.2	4.9	9.8	6.9	4.8	4.3	1.8	2.7	1.6	4.4	7.6	3.9	4.3	5.2	5.6	5.2	5.5	5.2	4.2	3.9	8.7	5.8	3.1	3.0	5.1	4.5	6.7	8.8	2.5	7.9	2.1	13.3	7.1	8.7	5.0	5.2	5.4	3.9	9.4	6.9	8.0	6.1	3.8	2.5	6.9	7.0	4.0	3.0	6.7	5.9	4.4	3.2	5.2	2.6	3.6	4.5	8.0	9.0	3.1	5.5	5.3	5.4	4.2	3.5	4.0	7.3	3.2	18.4	4.6	5.1	6.0	9.8	1.9	2.0	3.9	2.2	4.3	5.2	2.5	2.6	1.6	3.2	3.0	3.4	4.1	4.8	6.9	4.9	1.5	1.8	7.4	7.3	6.8	7.9	6.5	6.9	8.5	4.6	5.9	8.0
PUS3	FKSG32	ENSG00000110060	"Pseudouridylate synthase 3"	Q9BZE2	11	125893485-125903221	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038040, HPA063802"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038040: AB_10697092, HPA063802: "	"unprognostic (5.89e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.59e-2)"	"prognostic unfavourable (8.10e-4)"	"unprognostic (7.67e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.92e-3)"	"unprognostic (4.47e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.44e-1)"	8.6	8.8	5.9	7.4	7.7	2.3	8.7	9.0	8.4	7.4	9.2	3.6	4.6	9.9	8.4	8.6	8.1	6.4	5.9	7.6	8.0	6.4	9.6	36.6	6.1	11.0	8.7	7.2	7.7	17.9	8.2	21.1	7.6	7.7	10.4	7.4	5.4	10.6	5.1	15.2	8.2	11.5	13.9	9.7	8.9	9.3	5.3	7.3	9.6	12.4	10.6	9.2	11.1	7.3	13.0	8.8	9.9	12.3	13.0	16.5	7.1	3.5	4.3	13.3	14.9	13.7	17.5	6.4	11.9	10.0	6.8	7.6	14.1	13.4	18.1	19.6	5.2	12.4	21.6	11.0	6.9	15.4	10.4	18.6	5.5	10.1	14.5	11.7	5.5	13.8	13.3	8.1	17.4	12.5	18.9	9.5	7.3	2.1	13.0	12.5	11.5	8.5	2.6	12.2	10.2	11.2	5.6	15.5	13.8	8.1	11.4	6.5	24.3	7.6	8.4	14.4	5.9	6.8	9.8	7.1	10.6	19.1	3.9	18.8	9.8	9.9	9.7	7.8	13.0	9.4	15.2	13.0	12.8	12.5	8.8	12.2	16.5	15.6	3.7	13.0	12.3	7.8	12.9	7.1	5.9	7.7	9.0	8.4	8.0	6.4	8.7	7.2	7.7	7.3
RENBP	"RBP, RNBP"	ENSG00000102032	"Renin binding protein"	P51606	X	153935263-153944691	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 32.7;lymphoid tissue: 36.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 12.9;HMC-1: 43.9;SK-MEL-30: 29.0;U-266/84: 25.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 57.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA000428, HPA000522"	Enhanced						42000			"HPA000428: AB_1079799, HPA000522: AB_1079798"	"unprognostic (3.08e-1)"	"prognostic favourable (3.95e-4)"	"unprognostic (1.12e-2)"	"unprognostic (3.29e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.99e-1)"	"prognostic favourable (3.08e-5)"	"unprognostic (2.39e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.25e-2)"	"unprognostic (8.51e-2)"	12.7	11.1	7.8	11.2	16.8	8.6	8.4	2.3	11.5	4.2	6.2	11.3	1.1	7.4	2.1	6.0	3.0	2.5	5.7	8.7	9.4	9.1	32.7	4.6	12.8	12.1	16.9	7.4	1.2	1.6	1.8	3.4	8.1	11.6	3.6	3.0	9.6	3.4	2.0	1.4	5.2	7.5	4.5	12.7	36.5	4.4	1.4	13.5	3.0	2.9	1.1	4.4	5.7	2.9	1.1	0.6	5.3	3.1	0.3	0.9	0.7	0.0	0.0	1.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.9	0.0	0.0	2.5	0.0	0.0	0.0	0.5	9.8	0.0	0.8	7.6	0.0	43.9	0.3	0.0	0.0	0.0	0.0	2.8	3.4	0.0	0.2	2.0	0.1	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	29.0	0.0	3.4	0.4	0.0	0.3	0.0	0.0	4.4	25.2	1.7	0.9	4.6	3.4	2.9	2.0	5.3	0.3	1.4	0.3	1.1	0.1	0.1	0.2	0.6	0.9	0.4	4.5	0.3	3.1	0.6	0.0	0.7	7.8	16.8	2.3	11.5	9.4	9.1	16.9	7.4	11.6	13.5
RPE		ENSG00000197713	Ribulose-5-phosphate-3-epimerase	Q96AT9	2	210002565-210022259	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA036498, HPA036499"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA036498: , HPA036499: AB_10670109"	"unprognostic (5.07e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.34e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavourable (1.42e-6)"	"unprognostic (1.59e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (7.00e-6)"	"unprognostic (2.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.84e-2)"	19.4	26.9	20.6	16.7	28.0	14.6	22.6	26.4	27.7	18.7	19.7	23.3	20.7	17.4	27.8	21.5	24.0	17.6	17.3	17.2	21.1	21.0	26.7	23.3	19.4	21.6	21.7	21.7	22.9	14.1	14.8	41.9	24.4	18.6	20.5	26.6	18.9	18.3	27.9	12.3	17.2	16.0	27.1	25.8	15.6	19.8	11.9	19.7	23.5	25.2	14.5	23.2	24.1	20.2	8.6	28.9	8.0	20.5	30.5	10.7	11.3	21.0	27.2	17.7	17.8	28.8	27.9	30.4	27.7	22.2	26.3	35.4	39.2	32.2	14.2	18.2	21.4	20.7	26.0	29.5	40.3	17.0	18.4	26.2	40.0	36.5	39.3	27.8	20.2	19.5	29.4	30.2	39.4	34.2	26.4	19.8	21.6	33.5	15.1	24.2	26.0	20.0	19.0	21.1	20.3	30.4	31.4	21.3	12.2	23.4	22.9	18.5	19.7	32.0	28.0	35.4	23.5	17.2	25.5	11.8	15.0	30.4	25.6	27.5	22.8	6.9	17.3	8.0	10.2	20.5	8.9	8.6	8.0	9.6	28.9	8.4	10.7	9.6	1.7	30.5	13.7	10.6	10.7	11.3	20.6	28.0	26.4	27.7	21.1	21.0	21.7	21.7	18.6	19.7
RPEL1		ENSG00000235376	"Ribulose-5-phosphate-3-epimerase like 1"	Q2QD12	10	103245887-103248016	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.4;brain: 1.2;pituitary gland: 1.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.1;NB-4: 1.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA036498, HPA036499"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA036498: , HPA036499: AB_10670109"	"unprognostic (7.52e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.83e-1)"		"unprognostic (6.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.91e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.72e-2)"	"unprognostic (5.06e-2)"	0.0	0.1	0.1	1.0	0.3	0.1	0.1	1.2	0.2	0.0	0.0			0.3	0.4	0.4	0.1	0.0	0.0	0.1	0.1	0.3	0.3	0.0	0.0	0.4	0.1		0.0	0.8	0.0	1.2	0.2		0.1	0.0		0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.1	0.0	0.2			0.1		0.1	0.0	0.0	0.4	1.0	0.3	0.7	1.4	0.6	0.2	0.5	0.5	0.1	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.2	0.4	0.7	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.3	1.1	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	1.0	0.7	0.0	0.0	0.1	0.3	0.5	0.2	0.3	0.1	0.3	0.4	0.2	0.1	0.4	0.0	0.1	0.9	0.1	0.2	0.3	0.1	0.3	0.7	0.4	0.1	0.3	0.7	0.2	0.5	0.7	0.5	0.4	0.4	0.3	1.0	0.4	0.5	0.6	0.0	1.4	0.4	0.3	0.4	0.2										
RPIA		ENSG00000153574	"Ribose 5-phosphate isomerase A"	P49247	2	88691644-88750935	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042620, HPA057954"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"			4100000	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA042620: AB_10793980, HPA057954: "	"unprognostic (3.35e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.31e-1)"	"unprognostic (8.24e-2)"	"prognostic unfavourable (1.46e-5)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-3)"	"unprognostic (8.70e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (8.53e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.01e-2)"	"unprognostic (8.79e-3)"	12.9	8.8	6.6	15.6	7.0	43.0	12.1	11.1	6.4	8.1	12.7	6.1	11.0	12.4	11.1	7.3	18.3	8.5	14.0	10.9	5.0	4.9	6.8	6.2	9.0	16.2	7.2	3.8	11.7	26.5	3.6	11.4	26.1	6.5	8.8	13.4	6.0	12.6	8.5	17.6	9.2	12.7	7.7	5.1	15.4	10.4	8.9	7.6	30.7	9.6	10.5	19.3	8.1	11.8	18.5	14.1	21.4	12.5	13.3	22.4	11.6	8.5	5.0	10.2	8.0	7.2	7.4	22.3	4.8	4.5	7.9	5.4	17.8	11.4	43.7	10.4	5.5	5.2	12.6	4.0	12.5	20.7	16.5	17.5	3.2	17.5	7.3	32.0	12.9	6.8	3.4	7.0	11.0	11.1	18.7	7.6	7.4	13.4	35.1	28.0	9.2	8.2	18.4	12.1	10.6	6.5	13.8	7.3	8.3	5.7	7.4	11.0	4.0	13.2	6.3	4.7	12.4	15.4	13.6	5.9	4.8	43.7	4.8	29.1	6.7	5.5	9.7	21.4	11.1	9.8	14.2	18.5	15.5	16.4	14.1	15.4	22.4	18.4	2.3	13.3	12.5	6.8	12.6	11.6	6.6	7.0	11.1	6.4	5.0	4.9	7.2	3.8	6.5	7.6
SPO11	"CT35, SPATA43, TOPVIA"	ENSG00000054796	"SPO11, initiator of meiotic double stranded breaks"	Q9Y5K1	20	57329759-57343994	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Meiosis	"DNA-binding, Hydrolase, Isomerase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	142	"testis: 14.2"	"Group enriched"	"Detected in some"	19	"Daudi: 1.7;SiHa: 1.3;U-698: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																															0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SRR	"ILV1, ISO1"	ENSG00000167720	"Serine racemase"	Q9GZT4	17	2303383-2325260	"Enzymes, Predicted intracellular proteins"		"Allosteric enzyme, Isomerase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007529, CAB015343"	Approved		Approved	Vesicles				Vesicles		"CAB015343: AB_2195009, HPA007529: "	"unprognostic (2.96e-1)"	"unprognostic (7.86e-2)"	"unprognostic (6.01e-2)"	"prognostic favourable (6.20e-5)"	"unprognostic (3.05e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.32e-2)"	"unprognostic (9.97e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.85e-2)"	"prognostic favourable (8.16e-4)"	"unprognostic (5.17e-2)"	"prognostic favourable (2.45e-6)"	"unprognostic (6.14e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.84e-2)"	11.6	12.6	17.1	7.7	14.7	13.9	16.7	12.2	24.9	8.4	10.4	13.9	11.4	7.9	10.9	11.3	12.9	10.0	9.6	12.6	15.2	13.0	10.3	9.0	10.9	7.0	12.6	15.6	9.8	14.8	11.0	9.7	6.5	12.4	9.6	8.8	10.6	11.9	9.3	16.9	13.4	7.5	15.0	13.2	7.3	9.2	13.8	9.0	13.4	13.8	6.1	6.0	12.1	7.3	9.7	15.5	5.2	12.6	13.9	13.5	8.7	7.2	13.2	24.0	8.9	13.1	13.8	11.7	15.4	9.6	10.2	10.6	12.2	9.2	13.6	2.0	15.9	15.3	6.6	5.6	13.0	15.8	12.9	7.0	9.8	4.6	13.2	2.0	3.9	11.7	5.8	22.8	11.0	14.9	7.2	10.1	22.7	4.3	13.9	2.7	5.0	10.0	23.1	27.2	6.3	11.8	3.3	4.7	12.1	13.4	1.6	7.0	10.5	4.9	11.7	11.0	7.8	12.4	9.1	8.9	12.0	2.5	19.6	6.6	14.9	2.4	8.2	5.2	9.5	8.7	9.9	9.7	12.3	10.1	15.5	8.9	10.4	13.5	1.0	13.9	12.6	10.4	8.9	8.7	17.1	14.7	12.2	24.9	15.2	13.0	12.6	15.6	12.4	9.0
TBXAS1	"CYP5, CYP5A1, THAS, TS, TXAS, TXS"	ENSG00000059377	"Thromboxane A synthase 1"	P24557	7	139777051-140020325	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 67.1;lymphoid tissue: 51.7"	"Cell line enhanced"	"Detected in some"		"NB-4: 34.7;PC-3: 11.1;RPTEC TERT1: 9.9;U-937: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"basophil: 38.1;classical monocyte: 44.5;eosinophil: 45.2;intermediate monocyte: 67.1;myeloid DC: 18.7;neutrophil: 38.8;non-classical monocyte: 56.4"	"Group enriched"	"Detected in all"	20	"dendritic cells: 18.7;granulocytes: 45.2;monocytes: 67.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA031257, HPA031258, HPA031259"	Enhanced						32000000			"HPA031257: , HPA031258: AB_2673813, HPA031259: AB_2673814"	"unprognostic (4.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.41e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavourable (1.14e-4)"	"unprognostic (1.52e-1)"	"unprognostic (5.00e-3)"	"unprognostic (8.53e-2)"	"unprognostic (5.34e-2)"	13.5	7.7	6.6	17.6	8.9	13.8	5.4	1.5	5.6	3.7	6.3	13.9	0.8	6.5	3.2	4.1	3.4	5.0	13.9	3.7	7.6	5.7	6.1	8.1	20.3	43.9	12.6	2.0	2.5	3.1	1.4	3.5	9.0	9.0	5.2	8.6	4.4	8.2	2.6	1.6	1.9	9.3	7.9	19.3	51.7	7.1	2.0	12.7	7.5	2.4	2.2	6.1	9.3	2.5	1.3	18.7	45.2	67.1	1.5	2.2	25.1	0.1	3.0	0.1	0.0	0.6	1.9	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	4.5	0.3	8.2	0.0	0.0	0.8	2.7	7.3	1.0	0.0	0.0	0.4	1.0	0.2	1.0	0.3	0.0	1.0	34.7	0.1	11.1	1.3	0.0	0.5	9.9	0.0	0.1	0.5	0.1	0.0	0.3	0.0	6.6	0.9	0.2	0.1	0.6	0.5	2.3	0.4	0.1	0.2	28.2	0.8	38.1	44.5	45.2	1.1	67.1	1.7	1.3	2.2	0.6	18.7	0.5	0.3	0.2	38.8	1.5	56.4	3.3	2.0	25.1	6.6	8.9	1.5	5.6	7.6	5.7	12.6	2.0	9.0	12.7
TMX3	"FLJ20793, KIAA1830, PDIA13, TXNDC10"	ENSG00000166479	"Thioredoxin related transmembrane protein 3"	Q96JJ7	18	68673688-68715298	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014157	Uncertain				"Intracellular and membrane"					"HPA014157: AB_1858469"	"unprognostic (2.11e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.47e-2)"	"unprognostic (6.82e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.21e-3)"	"unprognostic (5.20e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.73e-1)"	"prognostic unfavourable (2.87e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-1)"	22.8	16.8	14.7	22.8	31.3	12.2	20.5	28.0	34.2	16.4	15.4	14.0	16.0	17.8	22.1	21.7	16.9	18.3	16.8	20.2	17.1	18.2	19.2	19.9	23.3	25.6	14.2	18.7	16.0	16.3	20.4	19.3	19.6	26.8	18.7	16.9	18.2	14.6	16.3	14.1	16.5	21.1	21.1	16.7	26.3	15.2	11.1	11.1	29.6	19.2	13.4	22.1	19.9	14.8	4.9	9.6	3.4	6.9	7.6	8.7	4.1	3.3	5.4	10.6	8.2	21.9	23.4	7.8	26.9	28.7	19.6	21.9	2.5	10.0	9.7	5.3	39.1	12.9	6.9	13.5	30.2	9.2	6.2	8.9	8.6	4.5	23.2	18.8	14.7	18.6	8.7	21.2	19.2	24.8	5.7	13.5	23.2	2.1	10.1	6.0	4.4	8.9	9.4	20.9	11.8	16.6	7.4	10.2	7.9	13.1	8.5	9.9	5.5	16.1	23.7	35.1	9.6	7.8	19.6	9.1	9.1	9.1	21.2	15.6	25.6	2.6	4.3	3.4	6.1	6.9	8.7	4.9	6.3	5.6	6.9	3.6	7.1	6.9	1.1	7.6	4.7	9.6	6.4	4.1	14.7	31.3	28.0	34.2	17.1	18.2	14.2	18.7	26.8	11.1
TOP1		ENSG00000198900	"DNA topoisomerase I"	P11387	20	41028818-41124487	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009058, HPA019039"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"CAB009058: AB_2303554, HPA019039: AB_1858187"	"unprognostic (1.46e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.49e-3)"	"prognostic unfavourable (6.42e-4)"	"unprognostic (5.86e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.51e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.14e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	26.6	31.0	24.6	46.3	25.3	55.3	37.4	39.6	31.1	21.3	30.0	11.1	26.7	29.7	22.9	22.5	36.0	20.5	29.2	21.0	23.0	18.3	31.8	32.7	37.9	38.6	21.9	20.9	25.5	22.5	22.2	39.9	43.9	25.2	23.3	27.2	13.6	25.3	34.3	26.2	24.6	48.4	23.1	27.4	36.9	26.7	14.2	24.2	54.2	31.5	25.1	40.6	25.2	41.7	9.0	17.2	18.4	11.1	5.8	8.2	4.6	21.5	15.1	28.3	23.1	11.5	13.7	28.0	19.5	17.2	22.7	20.7	39.6	27.2	61.5	20.9	10.1	21.0	33.9	31.2	33.3	13.3	17.3	78.4	12.1	28.1	29.9	33.8	27.0	15.5	16.7	22.1	36.4	23.7	34.0	21.4	25.6	47.9	47.7	21.4	22.8	28.1	40.8	26.6	32.7	24.2	20.1	23.5	16.3	30.6	19.0	19.8	21.1	30.3	23.2	18.4	15.6	17.0	20.9	13.6	15.2	71.7	24.7	19.0	17.4	9.1	9.2	14.3	6.5	9.2	8.2	9.0	7.2	6.8	8.6	8.7	7.7	6.9	18.4	5.8	11.1	17.2	7.9	4.6	24.6	25.3	39.6	31.1	23.0	18.3	21.9	20.9	25.2	24.2
TOP1MT		ENSG00000184428	"DNA topoisomerase I mitochondrial"	Q969P6	8	143304384-143359979	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001915, HPA021542"	Approved		Supported	Mitochondria				Mitochondria		"HPA001915: AB_1080331, HPA021542: AB_1858186"	"unprognostic (5.02e-3)"	"unprognostic (3.79e-2)"	"unprognostic (6.57e-2)"	"unprognostic (6.92e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.42e-2)"	"prognostic unfavourable (1.52e-7)"	"unprognostic (3.66e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.55e-3)"	"unprognostic (5.66e-3)"	11.7	13.5	8.1	13.7	9.8	33.0	22.1	2.2	10.3	14.7	10.7	4.5	3.9	6.0	10.0	7.4	14.9	11.3	11.0	5.9	8.8	5.6	9.6	22.5	8.5	11.4	6.9	8.1	27.0	15.9	5.9	8.6	5.9	7.3	14.7	8.0	5.9	11.0	10.8	5.7	15.4	8.3	8.8	6.8	11.4	9.3	18.1	6.4	25.1	19.2	9.6	11.4	14.0	30.9	16.7	18.8	11.7	5.5	0.2	14.3	4.7	7.5	11.6	4.9	18.2	7.0	7.8	8.7	3.5	4.5	6.4	6.6	14.5	10.9	22.2	13.2	4.9	8.1	10.4	6.5	5.5	8.7	15.9	19.5	6.5	14.6	7.9	13.0	21.2	7.9	6.9	5.3	7.8	7.6	23.3	8.7	5.6	31.5	57.7	25.9	8.5	19.9	7.3	6.4	33.2	4.7	12.2	8.7	10.6	10.0	9.0	18.1	5.9	21.7	5.0	4.4	18.1	5.0	9.0	4.7	4.9	11.3	7.5	19.5	5.3	11.7	5.5	0.2	3.5	3.2	3.6	16.7	6.4	4.8	18.8	8.0	14.3	10.4	0.4	0.2	0.6	16.4	1.7	4.7	8.1	9.8	2.2	10.3	8.8	5.6	6.9	8.1	7.3	6.4
TOP2A	TOP2	ENSG00000131747	"DNA topoisomerase II alpha"	P11388	17	40388516-40417950	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 146.3;testis: 36.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 5.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002448, HPA006458, HPA026773"	Enhanced	Approved	Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (5.92e-6)"	"prognostic unfavourable (4.99e-4)"	"unprognostic (6.21e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (3.83e-5)"	"unprognostic (5.03e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (7.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	2.7	2.0	0.4	20.0	0.5	14.6	4.1	0.4	0.5	3.0	6.9	0.5	0.5	7.0	2.0	3.4	18.2	0.7	2.4	2.3	0.6	0.5	1.4	1.9	5.5	15.4	0.6	0.4	1.2	1.1	0.0	0.4	10.7	0.6	1.2	8.0	0.6	3.2	0.3	0.6	5.9	9.2	2.6	1.8	7.3	4.5	36.8	0.3	146.3	0.9	11.8	16.7	3.2	5.7	1.3	0.3	0.3	0.3	3.2	5.7	1.1	33.7	44.9	57.2	26.1	2.8	5.8	12.7	46.4	25.0	42.7	37.9	21.0	25.9	54.5	23.6	15.7	53.8	43.9	18.5	57.4	29.1	29.3	36.0	28.7	35.1	0.2	50.4	38.3	1.2	1.5	30.0	30.6	22.4	38.9	37.4	46.1	11.7	58.4	33.9	23.7	17.9	49.6	88.8	22.6	10.3	21.6	33.8	24.3	37.4	46.7	14.7	39.2	23.2	14.7	28.2	39.7	32.5	44.5	21.5	24.3	47.6	15.9	34.8	46.9	0.3	0.0	0.0	0.6	0.0	0.0	1.3	0.9	0.9	0.3	0.4	0.2	0.1	0.3	3.2	0.3	0.0	5.7	1.1	0.4	0.5	0.4	0.5	0.6	0.5	0.6	0.4	0.6	0.3
TOP2B		ENSG00000077097	"DNA topoisomerase II beta"	Q02880	3	25597905-25664907	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"	"Autism spectrum disorder, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 104.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004601, HPA024120, HPA050441"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004601: AB_628384, HPA024120: AB_1858191, HPA050441: AB_2681127"	"unprognostic (2.90e-2)"	"unprognostic (5.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (1.86e-7)"	"unprognostic (7.86e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.08e-1)"	"prognostic favourable (2.43e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.93e-2)"	19.3	18.8	23.4	23.1	29.7	26.5	21.1	48.4	33.5	24.1	22.4	21.1	18.9	17.1	29.6	25.6	21.1	20.6	20.7	22.7	22.0	19.9	20.3	18.4	17.7	28.2	21.0	28.5	26.8	17.2	43.0	21.6	22.3	26.4	24.7	20.8	17.6	21.3	22.3	31.3	20.9	19.3	24.4	23.4	24.6	20.1	11.3	22.7	60.2	28.3	20.7	27.3	34.8	21.5	5.5	5.6	5.3	4.6	7.8	7.2	2.2	10.5	10.9	24.1	29.5	8.0	10.2	9.6	10.2	13.1	9.5	10.4	5.5	8.4	32.6	7.1	14.7	9.0	20.0	11.3	16.0	15.6	10.7	49.5	13.6	9.3	5.6	38.7	26.5	7.3	5.7	10.6	9.3	15.4	16.6	16.1	12.2	11.7	25.0	9.6	18.3	8.3	104.7	13.6	15.1	8.5	37.2	12.2	21.1	15.2	10.9	9.3	11.3	34.6	14.7	13.2	10.3	10.5	10.9	24.9	14.1	34.7	8.7	29.0	8.8	4.2	2.9	5.3	6.3	3.3	6.9	4.3	6.1	6.4	4.3	5.5	7.2	6.4	2.0	7.8	4.6	5.6	4.4	2.2	23.4	29.7	48.4	33.5	22.0	19.9	21.0	28.5	26.4	22.7
TOP3A	"TOP3, ZGRF7"	ENSG00000177302	"DNA topoisomerase III alpha"	Q13472	17	18271428-18315007	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, Disease mutation, Dwarfism, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002449	Approved									"CAB002449: AB_564037"	"unprognostic (5.49e-2)"	"unprognostic (9.04e-2)"	"unprognostic (8.99e-2)"	"unprognostic (7.24e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.33e-3)"	"unprognostic (6.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.74e-1)"	"prognostic favourable (1.39e-4)"	"prognostic unfavourable (4.59e-4)"	"unprognostic (5.58e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.53e-2)"	"unprognostic (5.05e-2)"	"unprognostic (6.05e-2)"	12.5	11.6	10.9	12.5	14.0	23.8	12.0	21.4	17.9	11.0	11.2	13.8	9.1	10.3	13.3	10.4	12.1	11.8	9.5	8.4	9.3	10.5	9.3	15.6	10.8	15.5	9.4	9.0	11.4	16.1	15.0	15.1	10.7	11.1	11.0	13.1	12.8	11.6	9.0	13.0	19.1	10.8	14.1	9.0	16.6	10.5	17.9	11.8	25.9	10.3	7.4	16.2	11.6	10.7	2.1	2.7	10.4	5.9	4.1	4.0	3.3	8.1	13.7	11.2	13.6	5.7	5.8	10.2	8.6	6.2	15.2	15.0	24.9	3.6	14.1	5.6	7.8	11.5	16.8	7.3	16.1	10.4	13.5	12.9	14.2	8.5	5.7	6.4	11.5	3.7	4.7	16.1	9.4	7.0	11.1	5.8	8.8	8.4	14.3	8.1	8.7	7.6	16.3	26.7	13.3	4.5	8.4	8.0	15.0	13.2	8.3	8.5	16.6	6.8	6.7	10.9	8.7	20.7	14.8	6.4	11.5	9.9	6.8	8.9	10.4	1.4	5.9	6.5	4.0	5.8	2.6	1.7	3.0	3.1	2.6	2.1	2.6	2.7	10.4	4.1	2.9	2.7	2.2	3.3	10.9	14.0	21.4	17.9	9.3	10.5	9.4	9.0	11.1	11.8
TOP3B		ENSG00000100038	"DNA topoisomerase III beta"	O95985	22	21957025-21982816	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 48.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072114			Approved	Nucleoplasm				Nucleoplasm		"HPA072114: "	"unprognostic (1.03e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.37e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.93e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.11e-4)"	10.4	11.7	12.1	16.1	17.4	20.8	10.9	17.2	17.1	12.5	11.0	16.9	14.9	15.4	16.1	11.0	14.2	11.0	11.2	10.1	12.7	5.5	13.4	15.3	12.7	17.0	18.7	6.5	20.2	12.1	13.5	21.0	12.1	16.2	15.6	14.9	14.1	13.3	13.3	13.4	17.5	16.1	14.5	17.4	23.6	11.8	11.1	16.9	13.1	14.2	5.7	18.9	10.5	14.3	9.0	8.8	2.7	6.8	6.1	9.3	5.2	9.5	9.1	18.7	7.4	6.9	5.8	11.7	6.4	7.9	14.7	13.1	9.9	4.1	13.1	4.8	6.6	17.5	8.4	11.2	11.9	6.7	20.2	10.3	11.8	10.2	9.4	14.0	6.8	2.8	17.3	12.1	5.9	12.2	48.2	7.2	6.9	9.7	8.8	10.9	7.7	8.8	13.8	12.4	2.0	7.3	12.8	12.2	8.9	7.8	6.9	5.9	5.4	9.0	8.9	6.1	12.7	5.7	7.7	10.6	8.6	12.4	4.7	8.6	6.2	2.5	6.7	2.7	9.3	6.8	6.5	7.5	5.8	6.5	7.4	9.0	5.9	5.7	2.3	6.1	3.8	8.8	6.7	5.2	12.1	17.4	17.2	17.1	12.7	5.5	18.7	6.5	16.2	16.9
TPI1		ENSG00000111669	"Triosephosphate isomerase 1"	P60174	12	6867119-6870948	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Glycolysis"	"Isomerase, Lyase"	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 234.8;skeletal muscle: 211.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050924, HPA053568"	Uncertain		Approved	Nucleoplasm,Vesicles			270000000	Nucleoplasm	Vesicles	"HPA050924: AB_2681276, HPA053568: AB_2682193"	"unprognostic (2.85e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavourable (1.04e-5)"	"unprognostic (4.14e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (6.54e-4)"	"unprognostic (7.04e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	20.2	41.2	41.2	24.3	46.9	27.4	83.4	93.2	196.1	27.1	39.1	12.8	18.6	40.1	17.2	22.6	51.0	22.1	33.3	94.9	36.7	33.1	43.1	40.8	48.8	140.2	34.0	34.6	19.9	87.0	32.1	16.8	27.1	70.7	19.0	43.5	21.1	26.0	28.7	211.0	25.8	37.8	29.4	20.8	20.1	21.6	15.7	19.4	14.2	20.2	38.4	38.0	23.0	28.0	55.4	170.3	145.5	148.2	81.2	67.1	234.8	119.2	106.9	56.6	87.6	55.5	58.6	100.1	86.3	95.3	163.1	197.9	110.3	65.6	70.0	17.4	85.1	59.4	134.6	144.2	181.0	92.3	100.3	90.7	78.3	72.7	41.4	103.2	74.5	63.6	60.2	125.8	108.4	99.1	46.9	26.9	125.2	87.8	54.2	87.2	139.7	68.1	31.9	93.2	71.8	102.1	85.1	40.3	67.1	75.3	78.4	41.8	17.9	77.6	61.2	87.5	75.0	56.6	126.5	52.6	21.6	104.6	175.6	64.2	62.7	87.7	146.1	145.5	56.1	148.2	57.0	55.4	56.5	54.5	170.3	44.3	39.9	49.3	61.1	81.2	127.8	30.7	67.1	234.8	41.2	46.9	93.2	196.1	36.7	33.1	34.0	34.6	70.7	19.4